<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2023.1135148</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>
<italic>In vitro</italic> models to study natural killer cell dynamics in the tumor microenvironment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Carannante</surname>
<given-names>Valentina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1012227"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wiklund</surname>
<given-names>Martin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1775828"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>&#xd6;nfelt</surname>
<given-names>Bj&#xf6;rn</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/30736"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Applied Physics, Science for Life Laboratory, KTH Royal Institute of Technology</institution>, <addr-line>Stockholm</addr-line>, <country>Sweden</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Center for Infectious Medicine, Department of Medicine Huddinge, Science for Life Laboratory, Karolinska Institutet</institution>, <addr-line>Stockholm</addr-line>, <country>Sweden</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Fabrizio Mattei, National Institute of Health (ISS), Italy</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Frank Momburg, German Cancer Research Center (DKFZ), Germany; Cai Zhang, Shandong University, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Valentina Carannante, <email xlink:href="mailto:carann@kth.se">carann@kth.se</email>; Bj&#xf6;rn &#xd6;nfelt, <email xlink:href="mailto:onfelt@kth.se">onfelt@kth.se</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>06</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1135148</elocation-id>
<history>
<date date-type="received">
<day>31</day>
<month>12</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>06</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Carannante, Wiklund and &#xd6;nfelt</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Carannante, Wiklund and &#xd6;nfelt</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Immunotherapy is revolutionizing cancer therapy. The rapid development of new immunotherapeutic strategies to treat solid tumors is posing new challenges for preclinical research, demanding novel <italic>in vitro</italic> methods to test treatments. Such methods should meet specific requirements, such as enabling the evaluation of immune cell responses like cytotoxicity or cytokine release, and infiltration into the tumor microenvironment using cancer models representative of the original disease. They should allow high-throughput and high-content analysis, to evaluate the efficacy of treatments and understand immune-evasion processes to facilitate development of new therapeutic targets. Ideally, they should be suitable for personalized immunotherapy testing, providing information for patient stratification. Consequently, the application of <italic>in vitro</italic> 3-dimensional (3D) cell culture models, such as tumor spheroids and organoids, is rapidly expanding in the immunotherapeutic field, coupled with the development of novel imaging-based techniques and -omic analysis. In this paper, we review the recent advances in the development of <italic>in vitro</italic> 3D platforms applied to natural killer (NK) cell-based cancer immunotherapy studies, highlighting the benefits and limitations of the current methods, and discuss new concepts and future directions of the field.</p>
</abstract>
<kwd-group>
<kwd>NK cells</kwd>
<kwd>tumor microenvironment</kwd>
<kwd>tumor spheroids</kwd>
<kwd>tumor organoids</kwd>
<kwd>microscopy</kwd>
<kwd>flow cytometry</kwd>
<kwd>tissue sectioning</kwd>
<kwd>live cell imaging</kwd>
</kwd-group>
<contract-sponsor id="cn001">Knut och Alice Wallenbergs Stiftelse<named-content content-type="fundref-id">10.13039/501100004063</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Vetenskapsr&#xe5;det<named-content content-type="fundref-id">10.13039/501100004359</named-content>
</contract-sponsor>
<contract-sponsor id="cn003">Stiftelsen f&#xf6;r Strategisk Forskning<named-content content-type="fundref-id">10.13039/501100011751</named-content>
</contract-sponsor>
<contract-sponsor id="cn004">Barncancerfonden<named-content content-type="fundref-id">10.13039/501100006313</named-content>
</contract-sponsor>
<contract-sponsor id="cn005">Cancerfonden<named-content content-type="fundref-id">10.13039/501100002794</named-content>
</contract-sponsor>
<counts>
<fig-count count="5"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="193"/>
<page-count count="19"/>
<word-count count="11175"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Cancer Immunity and Immunotherapy</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Immunotherapy comprises a large set of therapeutical strategies aimed at using or improving immune cell activity against tumors. Natural killer (NK) cells are NKp46<sup>+</sup> innate lymphocytes that participate in cancer immune surveillance, by eliminating tumor cells by cell-mediated cytotoxicity and pro-inflammatory cytokine release (<xref ref-type="bibr" rid="B1">1</xref>). Our ability to design efficient NK-based therapies requires broad knowledge of NK cell behavior in the tumor environment (TME) and screening platforms that reproduce such environments <italic>in vitro</italic>. NK cell activity has mostly been studied using two-dimensional (2D) cultures <italic>in vitro</italic>, and mouse models <italic>in vivo</italic>. These models have provided invaluable information in terms of phenotypic and functional characterization of NK cells. However, they present multiple limitations in terms of translational potential.</p>
<p>2D cell cultures are frequently used in research since they are easy to handle and well compatible with wide range of assays, especially if they involve cells growing in suspension, such as lymphocytes. However, a vast proportion of cells constituting human tissue are adherent. Generally, oxygen plasma-treated polystyrene surfaces in combination with serum-supplemented cell culture media are used to support cell adhesion and maintenance. Other materials that have been used in the microfluidic field and also demonstrated to be suitable for adherent cell growth include polydimethylsiloxane (PDMS) (<xref ref-type="bibr" rid="B2">2</xref>), cyclo-olefin polymer (<xref ref-type="bibr" rid="B3">3</xref>), polymethyl-methacrylate (<xref ref-type="bibr" rid="B4">4</xref>) and polycarbonate (<xref ref-type="bibr" rid="B5">5</xref>). Independently of the material used, adherent cells that interact with flat surfaces tend to distribute as monolayers. But cell monolayers are far from being representative of the three-dimensional (3D) architecture of the original tissue. The third dimension matters as the function of a cell in a tissue is dependent on its position in relation to the extracellular matrix (ECM) and the surrounding cells (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). The composition of the ECM, cell-to-cell adhesion and mechanical stress contribute to cell proliferation, differentiation, and migration (<xref ref-type="bibr" rid="B8">8</xref>&#x2013;<xref ref-type="bibr" rid="B11">11</xref>). The gradients of gas and nutrients in a tissue determine cell fate, shaping their metabolic and apoptotic programs (<xref ref-type="bibr" rid="B12">12</xref>&#x2013;<xref ref-type="bibr" rid="B14">14</xref>). Chemotactic gradients modulate the direction and dynamics of cell migration (<xref ref-type="bibr" rid="B15">15</xref>). This combination of biomechanical and biochemical cues present in the tissues might have significant implications for NK cell-mediated tumor surveillance and response to treatment (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>). Since 2D cell cultures show multiple limitations in reproducing the original features of human tissues (<xref ref-type="bibr" rid="B18">18</xref>), their use for research is usually complemented with mouse models, such as genetically engineered mouse models, patient-derived tumor xenografts and humanized mice. Mouse models can provide valuable information on the aetiology and the progression of diseases, as well as safety of therapies, but they are not optimal models for immunotherapy screening and precision medicine. Mouse models are also very expensive, not suitable for high-throughput testing, and they do not fully recapitulate the stromal composition of human tissue.</p>
<p>To overcome these limitations, a wide variety of techniques have been developed and optimized for routine use of 3D cultures in biological research (<xref ref-type="bibr" rid="B18">18</xref>&#x2013;<xref ref-type="bibr" rid="B21">21</xref>). 3D cultures are commonly categorized into scaffold-based and scaffold-free cultures. In scaffold-based 3D cultures, a substrate is provided to simulate the properties of ECM and promote cell adhesion (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>) (<xref ref-type="bibr" rid="B22">22</xref>&#x2013;<xref ref-type="bibr" rid="B28">28</xref>), and they are commonly applied in bone and myocardial tissue regeneration (<xref ref-type="bibr" rid="B29">29</xref>). Scaffold-free 3D cultures rely on the formation of multicellular aggregates by promoting the adhesion of cells to each other rather than to a substrate (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). Scaffold-free 3D cultures are low-cost and they guarantee high levels of reproducibility (<xref ref-type="bibr" rid="B18">18</xref>). Their main applications include studies of solid tumor models, immune cell-solid tumor interaction, drug screening and formation of organotypic models. The term &#x201c;spheroids&#x201d; generically refers to tight cellular aggregates with spherical shape (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). They can be composed of multiple cell types (heterotypic spheroids) or a single cell type (homotypic spheroids). The term &#x201c;organoids&#x201d; usually refers to 3D cultures composed of multiple cell types with specific localization and roles within the aggregates, resembling the composition, organization and function of the original tissue (<xref ref-type="bibr" rid="B30">30</xref>). Such specialization within the organoids is usually obtained driving the differentiation of stem cells (induced-pluripotent stem cells (iPS), primary stem cells, adult stem cells) <italic>in vitro</italic>. In this regard, organoids are effectively small reproductions of organs <italic>in vitro</italic> (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Overview of 3D cultures. <bold>(A)</bold> Illustration of scaffold-based 3D cell culture. Scaffolds resemble the ECM composition and 3D architecture of human tissues, providing support for cells to grow and differentiate <italic>in vitro</italic>. <bold>(B)</bold> Illustration of scaffold-free 3D cell culture. Often the substrate (gray) is coated by a non-adhesive, inert chemical (beige), which promotes cell-to-cell interaction, ECM and growth factor release, leading to the formation of self-sustained 3D cell cultures <italic>in vitro</italic>. <bold>(C)</bold> The illustration depicts the general features of organoids, such as multicellular composition, defined cellular distribution, cell differentiation and basolateral specialization of functions, such as EMC production in the basal area and fluid release in the apical area of cells.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1135148-g001.tif"/>
</fig>
<p>The boundaries between &#x201c;spheroids&#x201d; and &#x201c;organoids&#x201d; become less clear in the context of tumors, i.e. tissue that by definition lose structural and functional organization (<xref ref-type="bibr" rid="B31">31</xref>). For simplicity, we will collectively refer to 3D models used to recapitulate tumor tissue as &#x201c;tumor spheroids&#x201d;. In the following sections, we describe the currently available methods to characterize NK cell phenotype, cytotoxicity and infiltration in tumor spheroids, as well as their application in immunotherapy testing. The application of tumor spheroids in the NK cell field goes back to the late 70&#xb4;, their use remained sporadic until very recently. Nowadays, the development of new tools for culture and data analysis is boosting the application of tumor spheroids in NK cell research.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Natural killer cells</title>
<p>NK cells are innate lymphocytes that promote immune surveillance and tissue homeostasis (<xref ref-type="bibr" rid="B32">32</xref>). Fast activation is one of the key features of NK cells, which contributed to their discovery: in 1975, R. Kiessling, E. Klein and H. Wigzell reported their identification of &#x201c;naturally occurring lymphocytes&#x201d; able to &#x201c;spontaneously kill&#x201d; mouse Moloney leukemia cells (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>). The term &#x201c;spontaneously&#x201d; referred to their ability to be cytotoxic <italic>in vitro</italic> within an hour, without requiring prior exposure to the same tumor cells (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>). Rapid effector functions and lack of prior sensitization markedly distinguishes NK cells from T cells, that require 6 hours (with co-stimulation) up to 30 hours (in the absence of co-stimulation) to be fully activated (<xref ref-type="bibr" rid="B35">35</xref>). Cell-mediated cytotoxicity and pro-inflammatory cytokine release are the most prominent NK cell effector functions (<xref ref-type="bibr" rid="B36">36</xref>). However, multiple NK cell subsets with varying functions have been reported since their discovery.</p>
<p>NK cells express the cell surface marker NKp46, and they can be found in the body as circulating or tissue-resident cells (<xref ref-type="bibr" rid="B37">37</xref>). Circulating NK cells, also called &#x201c;conventional&#x201d; NK cells, represent 5-15% of peripheral blood mononuclear cells (PBMCs). They constantly travel between spleen, lymph nodes and inflamed tissues using blood and lymphatic vessels (<xref ref-type="bibr" rid="B38">38</xref>). Tissue-resident NK cells can be found in the liver, lung, adipose tissue, and uterus during pregnancy (<xref ref-type="bibr" rid="B39">39</xref>).</p>
<p>Two main NK cell subsets have been characterized in humans: CD56<sup>Bright</sup> CD16<sup>-</sup> and CD56<sup>Dim</sup> CD16<sup>+</sup> (<xref ref-type="bibr" rid="B40">40</xref>). CD56<sup>Bright</sup> CD16<sup>-</sup> NK cells are preferentially distributed in lymph nodes, tonsils, and uterus, and they show strong cytokine production (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B41">41</xref>). CD56<sup>Dim</sup> CD16<sup>+</sup> cells represent approximately 90% of circulating NK cells in blood and spleen, and their main features are cytotoxic activity and cytokine production (<xref ref-type="bibr" rid="B42">42</xref>). CD56<sup>Bright</sup> CD16<sup>-</sup> NK cells express high levels of CCR7 and L-selectin, while both receptors are absent on CD56<sup>Dim</sup> NK cells (<xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B44">44</xref>). On the other hand, CD56<sup>Dim</sup> CD16<sup>+</sup> NK cells present high levels of CXCR1, CX3CR1 and Chem23, chemokine receptors that drive their recruitment into inflamed tissues (<xref ref-type="bibr" rid="B45">45</xref>&#x2013;<xref ref-type="bibr" rid="B47">47</xref>). Migration into peripheral tissues is assisted by additional adhesion proteins, such as low-affinity ligands for E-selectin and P-selectin, that promote leukocyte rolling on the vascular bed, and high-affinity integrins that mediate firm adhesion to endothelial cells and subsequent trans-endothelial migration (<xref ref-type="bibr" rid="B1">1</xref>).</p>
<p>NK cytolytic activity is mediated by both release of perforin/granzyme granules and death receptor activation (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>) (<xref ref-type="bibr" rid="B48">48</xref>). Cytokines produced by NK cells comprise pro-inflammatory mediators, such as interferon &#x3b3; (IFN-&#x3b3;) and tumor necrosis factor-&#x3b1; (TNF-&#x3b1;), and immunosuppressive mediators, such as interleukin (IL)-10. NK cells also secrete growth factors, such as granulocyte macrophage colony-stimulating factor and granulocyte colony-stimulating factor (<xref ref-type="bibr" rid="B45">45</xref>), and several chemokines, including CCL2, CCL3, CCL4 and CCL5 (<xref ref-type="bibr" rid="B49">49</xref>). In addition, NK cells can perform antibody-depended cellular cytotoxicity (ADCC). ADCC is a potent type of cell-mediated cytotoxicity that relies on antibody crosslinking on the target cell (<xref ref-type="bibr" rid="B1">1</xref>). At early phases of immune responses, NK cells produce IFN-&#x3b3;, promoting the immunoglobulin isotype switch towards IgG in B cells. At late phases of the immune responses and during antigen re-challenge, NK cells use the CD16a receptor, also called Fc&#x3b3;RIIIa, to recognize target cells covered with IgG immunoglobulins. Such recognition induces a strong release of granzyme and perforin, that ultimately kills the target cell. ADCC also represents an example of cross-talk between NK cells and adaptive immunity.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Overview of NK cell functions.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1135148-g002.tif"/>
</fig>
<p>NK cell activation is regulated by a dynamic system of inhibitory and activating signals. This system mainly relies on cell surface receptors that discriminate between healthy and unhealthy cells (<xref ref-type="bibr" rid="B36">36</xref>). Thus, tumor cells become susceptible to NK cells due to increased expression of activating ligands and/or decreased expression of inhibitory ligands (<xref ref-type="bibr" rid="B50">50</xref>). The main NK cell activating receptors are CD16, NKG2D, DNAM-1 and the natural cytotoxicity receptors (NCRs) NKp30, NKp44 and NKp46 (<xref ref-type="bibr" rid="B51">51</xref>), while CD94/NKG2A (C-type Lectin superfamily glycoproteins) (<xref ref-type="bibr" rid="B51">51</xref>), TIGIT (<xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B53">53</xref>), LAG-3 and TIM-3 are inhibitory receptors. In addition, NK cells express KIR receptors, which are encoded by the KIR polygenic and polymorphic locus that includes both activating and inhibitory variants. Two KIRs haplotypes have been characterized in humans, A and B, differing in the amount of inhibitory and activating KIRs, respectively (<xref ref-type="bibr" rid="B54">54</xref>). KIR receptors recognize the ubiquitously expressed HLA class I molecules (HLA-A, HLA-B, HLA-C). NK cells constantly undergo a process of education that finely tunes their responsiveness, optimizing their ability to mount an immune response against cells with reduced HLA class I expression (typically virus-infected and tumor cells), while maintaining tolerance to self (healthy tissues expressing HLA class I) (<xref ref-type="bibr" rid="B55">55</xref>&#x2013;<xref ref-type="bibr" rid="B57">57</xref>). NK response is potentiated by co-stimulatory receptors, such as CD2 and 2B4, and cytokines, such as IL-2, IL-15, IL-12, IL-18 and IL-21 (<xref ref-type="bibr" rid="B58">58</xref>). Cytokine exposure, as well as receptor activation, can trigger the differentiation of memory NK subsets, defined as long-lived, self-renewing NK cells showing enhanced effector function and proliferative capacity during secondary exposure to pathogens (<xref ref-type="bibr" rid="B59">59</xref>).</p>
<p>The NK cell activities described so far are mainly pro-inflammatory. However, NK cells also play a major role in tissue homeostasis (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>) (<xref ref-type="bibr" rid="B39">39</xref>). Such a role is well-exemplified by decidual NK cells (dNK). dNK cells are poorly cytotoxic tissue-resident NK cells found in pregnant endometrial tissue to orchestrate placenta development. First, dNK cells produce angiogenic factors to re-model the uterine arterial system (<xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B61">61</xref>). Secondly, they control extra-villous trophoblast cell invasion of spiral arteries, releasing IL-8 and interferon-inducible protein-10 (IP-10) (<xref ref-type="bibr" rid="B62">62</xref>). Both steps are crucial for ensuring a positive outcome of pregnancy (<xref ref-type="bibr" rid="B63">63</xref>). NK cells exist also in the adult liver and adipose tissues. After liver damage, NK cells collaborate with macrophages and hepatic stellate cells (HSC) in the resolution of fibrosis. In addition, cytotoxic NK cells kill hepatic stellate cells, specifically discerning between quiescent and activated cells (<xref ref-type="bibr" rid="B64">64</xref>). In adipose tissue, NK can sustain a local Th1 response and contribute to obesity-associated metabolic disease (<xref ref-type="bibr" rid="B65">65</xref>). NK cells are also involved in the prevention of autoimmunity, being able to kill immature dendritic cells (DCs) (<xref ref-type="bibr" rid="B66">66</xref>) and activated T cells (<xref ref-type="bibr" rid="B67">67</xref>, <xref ref-type="bibr" rid="B68">68</xref>). In this review, we have primarily focused on the use of spheroids cultures to study the role of NK cells in cancer immune surveillance. However, multiple 3D models have been developed to study dNK cells and their role in pregnancy (<xref ref-type="bibr" rid="B69">69</xref>&#x2013;<xref ref-type="bibr" rid="B74">74</xref>).</p>
<p>NK cells are key players in cancer immune surveillance and a variety of NK cell-based therapies are currently being developed and tested in Phase I/II clinical trials. Their ability to perform ADCC is taken into consideration while designing antibody-based immunotherapeutic strategies, and a plethora of activating receptors and co-receptors are used to produce new chimeric antigen receptor (CAR)-NK products for cellular immunotherapy. Compared to T cells, NK cell-based therapies show a better safety profile, rarely inducing severe adverse effects such as cytokine release syndrome and neurotoxicity. In addition, NK cells are not involved in graft-versus-host disease reactions, allowing the development of cell products from multiple sources, such as allogenic donors, cell lines and iPS cells, without safety concerns. Despite being effective in the treatment of hematopoietic cancers, the efficacy of NK cells in solid tumors is dramatically suppressed by the TME. For instance, presence of hypoxia (<xref ref-type="bibr" rid="B75">75</xref>) and acidic pH (<xref ref-type="bibr" rid="B76">76</xref>) affect NK cell survival and activity in the solid tumors (<xref ref-type="bibr" rid="B76">76</xref>&#x2013;<xref ref-type="bibr" rid="B81">81</xref>). Tumor cells and fibroblasts cooperate in producing soluble factors that directly suppress NK cells, such as TGF-&#x3b2; (<xref ref-type="bibr" rid="B82">82</xref>), indoleamine 2,3-dioxygenase (<xref ref-type="bibr" rid="B83">83</xref>), adenosine and prostaglandin E2 (<xref ref-type="bibr" rid="B84">84</xref>). Expression of NK receptors and/or their corresponding ligands is often affected by the tumor microenvironment leading to decreased tumor recognition by NK cells (<xref ref-type="bibr" rid="B85">85</xref>&#x2013;<xref ref-type="bibr" rid="B87">87</xref>).</p>
<p>To better understand, predict and possibly target NK cell inhibition in the tumor microenvironment, tumor spheroid cultures that mimic solid cancers have been developed and adopted to NK cell research. In the next paragraphs, we will describe the currently available methods for spheroid formation applied to NK cell studies.</p>
</sec>
<sec id="s3">
<label>3</label>
<title>Methods of spheroid formation applied to NK cell studies</title>
<sec id="s3_1">
<label>3.1</label>
<title>Spinner cultures</title>
<p>The application of spheroid cultures in the immunology field began in the late 70&#xb4; as models to study tumor allografts. Few methods of spheroid formation were available at that time, and the &#x201c;spinner cultures&#x201d; were among those. The method is based on culturing tumor cells in spinner flasks at constant stirring rates, promoting cell-to-cell interaction while preventing cell adhesion to the bottom of the flask (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>) (<xref ref-type="bibr" rid="B96">96</xref>). Sutherland et&#xa0;al. established mouse mammary sarcoma spheroids incubating cells in spinner flasks for 3-4 weeks (<xref ref-type="bibr" rid="B88">88</xref>). The spheroids were then exposed to allogenic mixed lymphocyte cultures (<xref ref-type="bibr" rid="B88">88</xref>) or implanted in the peritoneal cavity of allogenic mice (<xref ref-type="bibr" rid="B89">89</xref>&#x2013;<xref ref-type="bibr" rid="B91">91</xref>) to study the effect of alloreactivity and immunization in solid tumors (<xref ref-type="bibr" rid="B88">88</xref>, <xref ref-type="bibr" rid="B90">90</xref>). The spheroid implants could then be recovered to characterize the composition and the rate of immune cell infiltration (<xref ref-type="bibr" rid="B89">89</xref>, <xref ref-type="bibr" rid="B91">91</xref>, <xref ref-type="bibr" rid="B97">97</xref>). Similarly, Iwasaki et&#xa0;al. used the method to study the infiltration and cytolytic capacity of lymphokine activated killer (LAK) cells in human malignant glioma spheroids (<xref ref-type="bibr" rid="B98">98</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Methods of spheroid formation applied to NK cell research. <bold>(A)</bold> Spinner cultures. Tumor cell suspensions are transferred into spinner flasks that provide constant agitation and promote cell aggregation. Spheroid formation is reached within days or a few weeks, depending on the adhesive properties of each cell type. Spheroids generated by spinner cultures have been exposed to allogenic lymphocyte cultures (upper panel to the right) and implanted in allogenic mice (lower panel to the right) to study NK cell infiltration and clearance of tumors (<xref ref-type="bibr" rid="B88">88</xref>&#x2013;<xref ref-type="bibr" rid="B91">91</xref>). <bold>(B)</bold> Liquid-overlay method. Cell suspensions are seeded into standard culture plates pre-treated with non-adhesive coatings, such as agarose or poly-HEMA, that indirectly promote spheroid formation by preventing cell adhesion to the plate. Gravity and cell confinement in wells facilitate cell aggregation (spheroids are obtained within a few days). NK cells can be co-cultured with tumor spheroids to study their infiltration and cytotoxic capacity <italic>in vitro</italic>. <bold>(C)</bold> Hanging-drop cultures. Drops of cell suspension is dispensed onto a standard culture plate, that is turned upside-down. Surface tension and gravity enforce the formation of a single spheroid per drop within a few days. <bold>(D)</bold> Illustrations of hanging-drop platforms compatible with long-term and high-throughput spheroid cultures, based on the general features of 3D Biomatrix and InSphero plates. Multiple drops are formed by transferring cell suspension into the inlets of an array plate. Liquid reservoirs prevent drop evaporation. After spheroid formation, each drop is displaced into a single well of an ULA plate by pipetting additional medium on top of the inlets or by centrifugation. From this point, the hanging drop-derived spheroids can be used as described in the liquid-overlay section. <bold>(E)</bold> Schematic representation of the microfluidic platform developed by Ayuso et&#xa0;al. (<xref ref-type="bibr" rid="B92">92</xref>). The microfluidic device consists of a central chamber filled with collagen type I hydrogel, hanging drop-derived spheroids and NK cells. Antibody solutions are perfused through two lateral channels covered with endothelial cells. <bold>(F)</bold> Schematic representation of the MIVO device developed by Marrella et&#xa0;al. (<xref ref-type="bibr" rid="B93">93</xref>, <xref ref-type="bibr" rid="B94">94</xref>). Alginate-derived spheroids are transferred into the top chamber of the MIVO device, which resembles a trans-well insert. NK cell suspensions are perfused through capillaries running under the chambers containing spheroids, allowing NK cells to migrate through the trans-well membrane and infiltrate the tumor spheroid (<xref ref-type="bibr" rid="B95">95</xref>). <bold>(G)</bold> USW-induced spheroid formation in microwell chip. Left panel: cells are seeded into a glass-bottom microwell array chip coated with non-adhesive coating. USW exposure induce the formation of single spheroids in the center of each well. This step is followed by a period of spheroid stabilization in the absence of USW. Once spheroids are formed, NK cells are seeded into the wells under USW exposure to promote NK cell-spheroid interaction. The characterization of NK cell infiltration and killing in tumor spheroids can be performed directly in the chip by imaging, or off-chip by retrieving the samples from the chambers. Right panel: illustration of the multichambered microwell chip with 16 chambers, each containing 36 microwells, giving a total of 576 microwells per chip.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1135148-g003.tif"/>
</fig>
<p>The spinner culture method allows great flexibility in terms of number of spheroids obtained, since different quantities can be produced simply scaling up or down the number of cells seeded and the volume of culture medium. The method is also easy-to-use and cost-effective. Areas of intense cell proliferation and necrosis, as well as cell migration and cell-to-cell interaction were detected within the spinner culture spheroids by image analysis (<xref ref-type="bibr" rid="B96">96</xref>, <xref ref-type="bibr" rid="B98">98</xref>&#x2013;<xref ref-type="bibr" rid="B100">100</xref>), making the method suitable to study tumor progression <italic>in vitro</italic>. In addition, proteomic profiling of glioma spinner cultures revealed substantial differences compared to monolayer cultures in terms of metabolism, antigen presentation and HLA-E expression, allowing He et&#xa0;al. to study the role of NKG2A in tumor resistance to NK cell therapy (<xref ref-type="bibr" rid="B101">101</xref>).</p>
<p>Nowadays, the application of spinner cultures to NK cell studies is quite rare, due to the limitations of the method. Cell aggregation is simply driven by cell-to-cell collision, limiting the use of the spinner cultures to cell types that adhere to each other without additional support. The incubation time is cell type-dependent, and a large variation of spheroid size can be observed within the same experiment, while many applications require homogeneously shaped and sized spheroid. In addition, the optimal stirring rate to prevent cell adhesion to the flask bottom might differ across cell types, requiring optimization steps for each experimental setup. Lastly, the process of spheroid formation cannot be monitored directly due to the constant agitation, and the spheroids need to be transferred to a different plate or substrate to be visualized by microscopy.</p>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Liquid-overlay method</title>
<p>A spheroid-formation method that addresses some of the limitations of spinner cultures is the liquid-overlay technique (<xref ref-type="bibr" rid="B102">102</xref>&#x2013;<xref ref-type="bibr" rid="B104">104</xref>). This technique involves covering cell culture surfaces with a thin layer of non-adhesive coating, preventing cell attachment to the substrate, and therefore favoring cell-to-cell interaction (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>) (<xref ref-type="bibr" rid="B103">103</xref>). Cell suspensions are simply transferred on top of the coated plates, and stable spheroid formation is obtained in a few days (<xref ref-type="bibr" rid="B102">102</xref>, <xref ref-type="bibr" rid="B104">104</xref>). The thin and the transparent coating allows direct assessment of spheroid formation with standard transmission and fluorescence microscopes, reducing the sample handling steps. The use of the coating itself reduces the optimization steps required in the spinner cultures to set the proper spinning rate for each cell type.</p>
<p>The mostly used non-adhesive coating is the agarose gel, obtained by dissolving agarose powder in distilled water or buffers (phosphate buffer solution, cell culture medium) at concentrations usually spanning from 0.5% to 1.5% w/v (weight/volume) (<xref ref-type="bibr" rid="B104">104</xref>&#x2013;<xref ref-type="bibr" rid="B106">106</xref>). Another commonly used non-adhesive coating is poly-2-hydroxyethyl methylacrylate (poly-HEMA) dissolved in ethanol (<xref ref-type="bibr" rid="B107">107</xref>). Apart from the chemical composition, agarose and poly-HEMA gels also differ in preparation time and long-term stability. The preparation of poly-HEMA plates requires three days (<xref ref-type="bibr" rid="B107">107</xref>), while agarose coating can be performed in few hours (<xref ref-type="bibr" rid="B104">104</xref>). However, poly-HEMA coated plates can be stored long-term at room temperature, while agarose gels are less stable, and degradation might occur over long-term cell cultures (<xref ref-type="bibr" rid="B108">108</xref>). In the last decades, multiple coatings have been developed that are commercially available as liquid solutions or through buying pre-coated culture plates. An example is represented by the ultra-low attachment (ULA) plates. ULA-plates are cell culture plates pre-coated with hydrophilic and neutrally charged hydrogel that prevents cell adhesion to the plastic. They are single-use and available in multiple formats.</p>
<p>Similar to spinner cultures, spheroids generated with the liquid-overlay techniques show necrotic (<xref ref-type="bibr" rid="B104">104</xref>&#x2013;<xref ref-type="bibr" rid="B106">106</xref>, <xref ref-type="bibr" rid="B109">109</xref>) and hypoxic (<xref ref-type="bibr" rid="B110">110</xref>) cores, deposition of ECM rich in collagen (I, III, IV, V) (<xref ref-type="bibr" rid="B111">111</xref>), fibronectin and laminin (<xref ref-type="bibr" rid="B112">112</xref>&#x2013;<xref ref-type="bibr" rid="B114">114</xref>), and cell-to-cell and cell-to-matrix communication (<xref ref-type="bibr" rid="B105">105</xref>). These features make the liquid overlay-derived spheroids biologically relevant <italic>in vitro</italic> models. The method has been used to characterize the cytolytic activity and infiltration of NK cells in human glioma spheroids (<xref ref-type="bibr" rid="B115">115</xref>, <xref ref-type="bibr" rid="B116">116</xref>), correlating NK activity with morphological and physical changes of the spheroids, such as loss of surface coherence (<xref ref-type="bibr" rid="B115">115</xref>), formation of cytoplasmic blebs (<xref ref-type="bibr" rid="B111">111</xref>), chromatin condensation (<xref ref-type="bibr" rid="B111">111</xref>, <xref ref-type="bibr" rid="B116">116</xref>) and weight variation (<xref ref-type="bibr" rid="B117">117</xref>). It has also been used to identify adhesion molecules (<xref ref-type="bibr" rid="B112">112</xref>), receptors (<xref ref-type="bibr" rid="B106">106</xref>, <xref ref-type="bibr" rid="B112">112</xref>, <xref ref-type="bibr" rid="B114">114</xref>, <xref ref-type="bibr" rid="B118">118</xref>&#x2013;<xref ref-type="bibr" rid="B120">120</xref>) and metabolic pathways (<xref ref-type="bibr" rid="B121">121</xref>) involved in NK cell infiltration and cytotoxicity, as well as to test therapeutic strategies that enhance NK cell activity (<xref ref-type="bibr" rid="B105">105</xref>, <xref ref-type="bibr" rid="B110">110</xref>, <xref ref-type="bibr" rid="B120">120</xref>, <xref ref-type="bibr" rid="B122">122</xref>&#x2013;<xref ref-type="bibr" rid="B128">128</xref>). Importantly, the liquid-overlay technique is compatible with the use of primary material (<xref ref-type="bibr" rid="B124">124</xref>, <xref ref-type="bibr" rid="B129">129</xref>&#x2013;<xref ref-type="bibr" rid="B131">131</xref>), allowing the maintenance of tumor tissue explants up to a few weeks <italic>in vitro</italic>, retaining connective tissue components, endothelial cells, macrophage-like cells and blood capillaries (<xref ref-type="bibr" rid="B116">116</xref>).</p>
<p>The simplicity and scalability of the liquid-overlay technique contributed to the vast application of this method to multiple areas of biology research, especially immunology. However, the method still presents some flaws. Compared to spinner flasks, tumor cells are subjected to even less forces inducing cell-to-cell interaction, as the method solely relies on cell self-aggregation in the absence of substrate anchorage. Accordingly, a substantial number of solid tumor-derived cell lines fail to form anything but loose cell aggregates rather than compact spheroids in the liquid-overlay platform (<xref ref-type="bibr" rid="B102">102</xref>, <xref ref-type="bibr" rid="B104">104</xref>, <xref ref-type="bibr" rid="B107">107</xref>). Interestingly, very low success rate of spheroid formation is observed using healthy, non-cancerogenic cells (<xref ref-type="bibr" rid="B102">102</xref>, <xref ref-type="bibr" rid="B104">104</xref>).</p>
<p>The ECM is essential player in cell-to-cell adhesion (<xref ref-type="bibr" rid="B132">132</xref>), and the quantity and the quality of ECM production by various cell types might influence their ability to form spheroids. Accordingly, the addition of ECM components to the liquid-overlay cultures has been shown to increase the spheroid tightness in some tumor models (<xref ref-type="bibr" rid="B107">107</xref>). Another strategy to improve the success rate of spheroid formation is to use U-bottom multi-well plates: gravity forces combined with the U-shaped well geometry promote cell sedimentation in the middle of the well, increasing the probability of cell-to-cell interactions. This strategy addresses the issue of multiple and heterogeneous spheroid formation, as single and homogeneous spheroids per well are more frequently obtained compared to other plate formats. In addition, spheroid confinement in a single well facilitates the detection of qualitative and quantitative spheroid changes over time by live-imaging. However, the U-shape and the optical properties of the commonly used plastic surfaces are not compatible with high-quality and high-resolution imaging, and sample transferring is still required for detailed analysis of biological processes, possibly affecting the integrity of the sample.</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Hanging-drop method</title>
<p>The hanging-drop method is another popular technique for spheroid formation (<xref ref-type="bibr" rid="B133">133</xref>). Hanging drop cultures can be obtained by simply dispensing small aliquots of cell suspension (15-25 &#x3bc;l) in a plate, which is subsequently placed upside-down (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). Gravity enforces cell assembly at the liquid-air interface at the bottom of the hanging drops, and one-spheroid per drop is usually obtained within a few days (<xref ref-type="bibr" rid="B133">133</xref>&#x2013;<xref ref-type="bibr" rid="B135">135</xref>). The liquid drops are preserved due to surface tension but evaporation needs to be limited in long-term cultures to maintain appropriate osmolality levels (<xref ref-type="bibr" rid="B136">136</xref>).</p>
<p>Tung et&#xa0;al. developed a hanging drop platform for long-term culture and high-throughput analysis (<xref ref-type="bibr" rid="B136">136</xref>). Cell suspensions is pipetted into the 384 holes of an array plate, where the hydrophilic surface and gravity favor the formation of the hanging drops. Liquid reservoirs at the edge of the plate and a tray filled with water provides humidity while a plate lid limits evaporation (<xref ref-type="bibr" rid="B136">136</xref>). This implementation overcomes some drawbacks of the original hanging-drop method, such as rapid dehydration and laborious sample handling. This platform is commercially available in multiple formats from 3D Biomatrix.</p>
<p>InSphero developed a user-friendly hanging-drop platform compatible with long-term cultures and high-quality imaging. The InSphero culture system follows the 3D Biomatrix design, with a hanging-drop array made of multiple inlets inserted between a lid and a liquid reservoir (<xref ref-type="bibr" rid="B137">137</xref>). A distinct feature of the InSphero method is that the formed spheroids are transferred into a ULA-plate (Gravity-Trap ULA plate or Akura plates) by adding liquid on top of the inlets or by centrifugation. The spheroids can be maintained in the ULA plates for long-term culture, where liquid evaporation occurs at slow rate, and media exchange can easily be performed (<xref ref-type="bibr" rid="B138">138</xref>). The spheroids are confined in a small area (1 mm-diameter) at the bottom of the well, which is flat and made of thin clear plastic, facilitating live, automated and high-quality imaging (<xref ref-type="bibr" rid="B138">138</xref>&#x2013;<xref ref-type="bibr" rid="B140">140</xref>). A similar implementation is also available nowadays from 3D Biomatrix (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>). The 3D Biomatrix and InSphero platforms are compatible with both manual and fully automated handling.</p>
<p>The hanging drop method generates spheroids from a variety of cell types, such as tumor cell lines or cells derived primary tumors or healthy tissue (<xref ref-type="bibr" rid="B102">102</xref>, <xref ref-type="bibr" rid="B125">125</xref>, <xref ref-type="bibr" rid="B133">133</xref>). Cell differentiation and extensive secretion of extracellular matrix (<xref ref-type="bibr" rid="B133">133</xref>), as well as inner regions of necrosis and hypoxia (<xref ref-type="bibr" rid="B141">141</xref>) have been described. Herter et&#xa0;al. obtained heterotypic spheroids of adenocarcinoma cells and fibroblasts (<xref ref-type="bibr" rid="B142">142</xref>). The heterotypic spheroid model has been used to evaluate the combinatorial effect of IL-2 variant and tumor- or fibroblast-targeted T cell bispecific antibodies on T, NK and NKT cell activation, cytokine and chemokine secretion, spheroid killing and infiltration (<xref ref-type="bibr" rid="B142">142</xref>). Interestingly, the fibroblasts spontaneously arranged in the spheroid core, as also reported by others using different cell types and spheroid culture methods (<xref ref-type="bibr" rid="B122">122</xref>, <xref ref-type="bibr" rid="B139">139</xref>, <xref ref-type="bibr" rid="B142">142</xref>). The hanging drop technique has also been applied to immune therapy screening, for instance to test the effect of rituximab on NK cell ADCC in primary follicular lymphoma spheroids (<xref ref-type="bibr" rid="B125">125</xref>), and to evaluate different protocols of NK cell activation in colorectal carcinoma models (<xref ref-type="bibr" rid="B135">135</xref>). In summary, the hanging drop method is an easy-to-use technique to generate biologically relevant tumor models <italic>in vitro</italic>, it is compatible with multiple end-point assays, live and high-quality imaging, and high-throughput screening. However, the hanging-drop method does not fully address the problem of heterogeneous structural integrity between cell lines, as multiple cases of loose aggregates can be found literature (<xref ref-type="bibr" rid="B133">133</xref>).</p>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Scaffold-based spheroid cultures</title>
<p>
<italic>In vivo</italic>, NK cells migrate through the supportive tissue, and the stroma composition influences their infiltrative capacity, as well as tumor aggressiveness and therapeutic responses. Similarly, the spheroid stiffness, together with the amount and the composition of the ECM, shapes NK cell activity <italic>in vitro</italic> (<xref ref-type="bibr" rid="B112">112</xref>, <xref ref-type="bibr" rid="B115">115</xref>, <xref ref-type="bibr" rid="B143">143</xref>, <xref ref-type="bibr" rid="B144">144</xref>). Therefore, the properties of the ECM should be considered when evaluating NK cell-spheroid interactions.</p>
<p>A strategy to include ECM-like conditions and chemokine gradients in the assays is to introduce scaffolds in the cultures. Examples of such scaffolds are hydrogels or porous inserts that can be obtained from animals (e.g., fibrous gelatin, collagen, Matrigel, chitosan, hyaluronic acid, silk fibroin), plants (e.g., alginate) or by synthetic production (e.g., polyethylene glycol, polylactic acid, poly-&#x3f5;-caprolactone, polyurethans) (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B145">145</xref>). Scaffolds used in NK cell 3D research are mostly hydrogel-based, and they include Matrigel (<xref ref-type="bibr" rid="B95">95</xref>, <xref ref-type="bibr" rid="B144">144</xref>, <xref ref-type="bibr" rid="B146">146</xref>), collagen type I hydrogels (<xref ref-type="bibr" rid="B92">92</xref>, <xref ref-type="bibr" rid="B143">143</xref>, <xref ref-type="bibr" rid="B147">147</xref>&#x2013;<xref ref-type="bibr" rid="B149">149</xref>), alginate hydrogel (<xref ref-type="bibr" rid="B95">95</xref>, <xref ref-type="bibr" rid="B150">150</xref>) and functionalized hydrogel based on polyethylene glycol (PEG) (<xref ref-type="bibr" rid="B151">151</xref>).</p>
<p>Schnalzger el al. established heterotypic cultures of normal and tumor colon organoids together with primary fibroblasts in Matrigel to evaluate the efficacy and the specificity of EpCAM-CAR-NK92 cells (<xref ref-type="bibr" rid="B144">144</xref>). Similarly, Gopal et&#xa0;al. tested NK92-CD16 cytotoxicity in combination with chemotherapy and antibody-based immunotherapy against pancreatic and breast cancer cells embedded in Matrigel, using a newly designed high-throughput micropillar-microwell sandwich platform (<xref ref-type="bibr" rid="B146">146</xref>).</p>
<p>Ayuso et&#xa0;al. combined the use of hanging drop spheroid formation (scaffold-free method), rat-derived collagen type I hydrogel (scaffold-based method) and microfluidics to study antibody penetration, ADCC, and NK cell chemotactic migration and infiltration in breast cancer spheroids (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3E</bold>
</xref>) (<xref ref-type="bibr" rid="B92">92</xref>). This microfluidic device consisted of a central chamber filled with collagen type I hydrogel, flanked by two lateral lumens covered with endothelial cells to mimic blood vessels. Hanging drop-derived spheroids were transferred into the central chamber and embedded together with NK cells in collagen, while a solution containing IL-2-conjugated CD16-EpCAM bispecific antibody was perfused through the later lumens. Using this method, the authors could follow the dynamic of antibody penetration, NK cell chemotactic migration and ADCC by imaging (<xref ref-type="bibr" rid="B92">92</xref>).</p>
<p>Marrella et&#xa0;al. developed alginate spheres to study the effect of IFN-&#x3b3; exposure on NK cell ligand expression in neuroblastoma spheroids (<xref ref-type="bibr" rid="B150">150</xref>). The same group combined the use of alginate spheres with the MIVO fluidic platform (<xref ref-type="bibr" rid="B93">93</xref>, <xref ref-type="bibr" rid="B94">94</xref>) to study the mechanisms of NK cell extravasation and tumor infiltration (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3F</bold>
</xref>) (<xref ref-type="bibr" rid="B95">95</xref>). The MIVO platform consists of a trans-well system connected to a closed-loop fluidic circuit (<xref ref-type="bibr" rid="B93">93</xref>, <xref ref-type="bibr" rid="B94">94</xref>). The top chamber of the trans-well (donor chamber) contained alginate-derived neuroblastoma spheroids. NK cells were constantly perfused through the bottom chamber (receiver chambers) and the capillaries of the fluidic circuit, which mimics the blood circulation. The porous membrane physically separating the donor and the receiver chambers prevented alginate spheres to fall into the receiver chamber (<xref ref-type="bibr" rid="B95">95</xref>). The spheroids and the cell suspension could be recovered and used for a variety of end-point analysis. For instance, the authors used flow cytometry to compare the proportion of CD16<sup>+</sup> CD45<sup>+</sup> cells in circulating, extravasated and spheroid-infiltrated NK cells (<xref ref-type="bibr" rid="B95">95</xref>).</p>
<p>Animal- and plant-derived hydrogels, such as collagen and Matrigel, present some limitations, such as batch-to-batch variability, long-term instability, cell degradation and immunogenicity, therefore synthetic hydrogels might be preferred for some applications (<xref ref-type="bibr" rid="B28">28</xref>). For instance, Temple et&#xa0;al. developed arginine-glycine-aspartic acid functionalized PEG hydrogels to study the effect of matrix metalloproteinases and integrins on NK cells migration (<xref ref-type="bibr" rid="B151">151</xref>). The authors also showed decreased NK cell infiltration in non-small lung cancer 3D cultures releasing soluble MICA and TGF-&#x3b2; (<xref ref-type="bibr" rid="B151">151</xref>).</p>
<p>The scaffold-based spheroid cultures are biologically relevant systems to study leukocyte transmigration and tissue infiltration, however they are often not compatible with high-throughput screening and live cell imaging. This, combined with the fact that the procedures to recover cells from the hydrogels are quite laborious, limits their large-scale application, and it is one of the reasons why scaffold-free technologies are still usually preferred.</p>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Miniaturized platforms for spheroid studies</title>
<p>Another strategy to enhance the interplay of spheroid and NK cells is the use miniaturized cell culture platforms. In miniaturized platforms, the well dimensions are tailored to the spheroid dimension, ensuring physical confinement, facilitating cell detection and cell-to-cell interaction. The miniaturization scales down the volumes and cell number required to set up and maintain cultures, enabling spheroid formation when the material is scarce (as with many patient samples). We already described a few examples of scaffold-based microfluidic and miniaturized platforms in the previous paragraph (<xref ref-type="bibr" rid="B146">146</xref>, <xref ref-type="bibr" rid="B148">148</xref>). Here, we will focus on scaffold-free miniaturized spheroid cultures for NK cell research.</p>
<p>Nguyen et&#xa0;al. designed a miniaturized microfluidic platform to enhance NK interaction with tumor and cardiac spheroids and study the specificity of NK cell killing and the secondary effects on healthy tissue (<xref ref-type="bibr" rid="B152">152</xref>). Their microchip, adapted from the Akura Flow MPS discovery platform (<xref ref-type="bibr" rid="B153">153</xref>), features two individual perfusion channels with 10 communicating compartments and medium reservoirs at both ends (<xref ref-type="bibr" rid="B152">152</xref>, <xref ref-type="bibr" rid="B153">153</xref>). Spheroids were formed in ULA plates and then transferred into the compartments, and NK cells were introduced to the cultures through the medium reservoirs. Perfusion across the medium reservoirs and the spheroid compartments, and therefore NK-spheroid interaction, was driven by gravity simply tilting the microchip along its long axis. The process is automated using a tilting stage (<xref ref-type="bibr" rid="B152">152</xref>, <xref ref-type="bibr" rid="B153">153</xref>). The authors showed the relevance of the method by perfusing umbilical cord blood (UCB)-derived NK cells into colorectal tumor spheroids and cardiac microtissues placed in distinct communing compartments. The experiment demonstrated the specificity of UCB-NK cell cytotoxicity towards colorectal tumor spheroids, but it also showed the presence of infiltrating UCB-NK cells in the cardiac spheroids along with signs of arrhythmia, possibly induced by pro-inflammatory cytokines detected in the supernatant (<xref ref-type="bibr" rid="B152">152</xref>). Cells and culture medium can easily be recovered by pipetting for cellular and proteomic analysis, while end-point imaging can be performed directly on the chip. However, dynamic of NK cell adhesion and infiltration cannot be entirely followed by live imaging, due to the tilting procedure, and the spheroid culture cannot be performed directly on the microchip.</p>
<p>Our group has developed a scaffold-free microwell chip platform to study the dynamics of NK cells in tumor spheroids (<xref ref-type="bibr" rid="B154">154</xref>&#x2013;<xref ref-type="bibr" rid="B156">156</xref>). One of the main advantages of this platform is that all the experimental phases (spheroid formation, treatment and NK cell incubation, analysis) can be performed on the chip, which is compatible with high-resolution and live cell imaging. Spheroids and NK cells can also be retrieved by standard pipetting for off-chip analysis (<xref ref-type="bibr" rid="B155">155</xref>). The spheroid formation is obtained by seeding cell suspensions in a silicon microwell array chip covered with a non-adhesive coating and inducing cell aggregation by ultrasonic standing waves (USW) (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3G</bold>
</xref>) (<xref ref-type="bibr" rid="B155">155</xref>, <xref ref-type="bibr" rid="B156">156</xref>). In microfluidics and other miniaturized systems, ultrasound has found use in various applications where either suspended cells or the fluid is manipulated by acoustic radiation pressure. This technology field is often called microscale acoustofluidics (<xref ref-type="bibr" rid="B157">157</xref>). We specifically use this technology to induce cell aggregation and formation of single, homogeneous and compact spheroids in each well (<xref ref-type="bibr" rid="B154">154</xref>, <xref ref-type="bibr" rid="B158">158</xref>&#x2013;<xref ref-type="bibr" rid="B161">161</xref>). When the USW is turned off, cellular production of ECM proteins and formation of tight intercellular connections continue, enabling long-term spheroid cultures. Importantly, acoustic trapping is also performed while setting up the co-cultures, to induce NK cell-spheroid interaction (<xref ref-type="bibr" rid="B156">156</xref>, <xref ref-type="bibr" rid="B161">161</xref>). Importantly, the physical force field of the USW is gentle to cells even at long continuous exposures (several days) (<xref ref-type="bibr" rid="B157">157</xref>).</p>
<p>Different microwell chip designs have been developed during the years (<xref ref-type="bibr" rid="B155">155</xref>, <xref ref-type="bibr" rid="B156">156</xref>, <xref ref-type="bibr" rid="B159">159</xref>, <xref ref-type="bibr" rid="B161">161</xref>). The most recent is a multichambered microwell chip, with 16 compartments each containing 36 microwells, allowing the simultaneous production and analysis of 576 spheroids (36 spheroid replicates for each experimental condition) (<xref ref-type="bibr" rid="B156">156</xref>). The microwell array is made in silicon, which is bonded to a glass bottom layer that is compatible with high-quality imaging. A thin and transparent non-adhesive coating is applied at the bottom of the wells to prevent cell adhesion (<xref ref-type="bibr" rid="B162">162</xref>). A PDMS frame separates the wells into compartments serving as liquid reservoirs (typically 50 &#x3bc;l are used for each compartment). Contamination and evaporation are prevented by placing a coverslip on top of the PDMS frame (<xref ref-type="bibr" rid="B156">156</xref>).</p>
<p>Fast image acquisition combined with high-resolution imaging enables high-throughput screening at chamber levels with detailed analysis of biological processes at the single microwell level. The method allowed studies of how combinatorial treatments affect NK cell infiltration and activity in tumor spheroids, quantifying the amount and the timing of killing (<xref ref-type="bibr" rid="B155">155</xref>). The method is also compatible with the formation of a wide range of homotypic spheroids (kidney, thyroid, ovarian, hepatic, non-small lung cancer cell carcinomas) (<xref ref-type="bibr" rid="B155">155</xref>, <xref ref-type="bibr" rid="B156">156</xref>, <xref ref-type="bibr" rid="B161">161</xref>), heterotypic and patient-derived spheroids (unpublished results), the latter particularly facilitated by the low material requirement.</p>
<p>The main limitations of the miniaturized platforms described here are related to the number of conditions that can be tested in parallel and the number of cells that can be retrieved from the chips for further analysis.</p>
<p>In this section, we have described the methods used for spheroid formation in the field of NK cell research. Each technique presents advantages and limitations, which should be carefully evaluated when choosing experimental strategy. The choice of method to use should be driven by two main questions: Which method provides the most relevant 3D features to study the mechanisms of interest? Which method is compatible with the analysis/assays we want to perform? In the next section, we will describe the available assays to characterize NK cell behavior and phenotype in cancer spheroids.</p>
</sec>
</sec>
<sec id="s4">
<label>4</label>
<title>Methods to study NK cell activity in tumor spheroids</title>
<p>The discovery of novel cell types and their characterization is closely related to our ability to detect their function. As a matter of fact, various immune cell types have been identified through observation of their activity, which historically preceded their phenotypic characterization. This is also the case for NK cells, initially identified for their ability to &#x201c;spontaneously kill&#x201d; tumor cells <italic>in vitro</italic> (<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B163">163</xref>, <xref ref-type="bibr" rid="B164">164</xref>), and later characterized for their serial killing capacity in single cell screening assays (<xref ref-type="bibr" rid="B165">165</xref>&#x2013;<xref ref-type="bibr" rid="B167">167</xref>). A variety of well-established assays and cutting-edge technologies are routinely used to screen NK cell activity on tumor cell monolayers (<xref ref-type="bibr" rid="B165">165</xref>, <xref ref-type="bibr" rid="B167">167</xref>&#x2013;<xref ref-type="bibr" rid="B174">174</xref>). However, a limited number of them is suitable for studying NK cell cytotoxicity in tumor spheroids.</p>
<p>Compared to 2D systems, developing functional assays for 3D cultures is more demanding. The challenges are intrinsically related to the physical properties of the spheroids. Accurate imaging of 3D objects beyond &#x2248;50 &#x3bc;m is challenging. High cellular density and ECM deposition generate light scattering, limiting the detection of NK cytotoxicity in the inner areas of the spheroids. Therefore, enzymatic dissociation or tissue sectioning are performed to isolate and characterize infiltrating NK cells, but these processes cause loss of spatial information and dynamics. In addition, introducing sample processing steps slows down the analysis and might cause experimental artifacts. Consequently, very few technologies that combine high-throughput cytotoxicity screening and high-resolution analysis of killing mechanisms are available, and multiple methodologies might be required to fully dissect NK cytotoxicity in tumor spheroids.</p>
<p>A lot of research is currently undergoing to overcome these limitations. In this section, we describe the methodologies described in literature.</p>
<sec id="s4_1">
<label>4.1</label>
<title>Bulk assays or methods based on radioisotope-cell labeling and luminescence</title>
<p>Traditionally, Chromium-51 (<sup>51</sup>Cr) release assay has been the gold-standard method to quantify NK cell cytotoxicity against tumor cell suspension or monolayers (<xref ref-type="bibr" rid="B175">175</xref>). The procedure involves culturing NK cells with tumor cells pre-labeled with sodium chromate. NK cell cytolytic activity causes loss of tumor cell membrane integrity, and consequent release of <sup>51</sup>Cr radioisotope in the supernatant, which can be detected by either &#x3b3; or &#x3b2; counters. Thus, quantification of the released <sup>51</sup>Cr is a measurement of NK cell cytotoxicity. Being quantitative, <sup>51</sup>Cr release assay is particularly adapted to compare the susceptibility of different cell types to various immunotherapeutic treatments (<xref ref-type="bibr" rid="B175">175</xref>).</p>
<p>
<sup>51</sup>Cr release assay has also been used to study NK cell cytotoxicity against tumor spheroids (<xref ref-type="bibr" rid="B115">115</xref>, <xref ref-type="bibr" rid="B129">129</xref>, <xref ref-type="bibr" rid="B130">130</xref>, <xref ref-type="bibr" rid="B176">176</xref>), coupling the conventional quantification of killing with the identification of dead areas by autoradiography (<xref ref-type="bibr" rid="B115">115</xref>). While ensuring high sensitivity, the use of radioactive material also represents the main limitation of the method. Multiple precautions should be taken while using <sup>51</sup>Cr to ensure the staff safety and proper waste disposal, and license to work with radioactivity must be granted. This limitation motivated the development of colorimetric and luminescence assays to measure the release of non-radioactive intracellular contents, such as lactate dehydrogenase (LDH) and adenosine 5&#xb4;-triphosphate.</p>
<p>LHD is a cytosolic enzyme that catalyses the conversion of lactate to pyruvate via NAD<sup>+</sup> reduction to NADH. NADH is a used by the reductase as co-factor to catalyze reduction reactions. A typical strategy to measure the LHD released in the supernatants of NK and spheroid co-cultures is to use a mix containing the reductase, its substrate, together with lactate and NAD. For instance, the LHD assay has been used by Murphy et&#xa0;al. to show the importance of addressing hypoxia to improve the efficacy of cell therapy (<xref ref-type="bibr" rid="B110">110</xref>). To increase the oxygen supply in the spheroid core, they developed biocompatible poly(lactic-co-glycolic) manganese dioxide nanoparticles (PLGA-MnO<sub>2</sub> NPs) that catalyse oxygen production from tumor-derived hydrogen peroxide. By treating hypoxic breast cancer spheroids with PLGA-MnO<sub>2</sub> NPs, they demonstrated a decreased presence of HIF-1&#x3b1;<sup>+</sup> tumor cells in the core associated with a significant reduction of immunosuppressive factors such as adenosine and lactate production. This phenotype was accompanied by an increased NK cell-mediated cytotoxicity and IFN-&#x3b3; production in the treated spheroids (<xref ref-type="bibr" rid="B110">110</xref>).</p>
<p>Bulk methods are high-throughput, therefore good for screening NK activity against multiple targets and combinatorial treatments. However, they provide no information about cell phenotype, neither the kinetics and the localization of NK cell killing and infiltration. Therefore, they are mainly used as end-point assays for screening multiple conditions, sometimes used as a guide for finding the best experimental conditions and performing more detailed analysis by flow cytometry or imaging.</p>
</sec>
<sec id="s4_2">
<label>4.2</label>
<title>Flow cytometry of tumor spheroids</title>
<p>Flow cytometry provides a rapid, quantitative and multi-parametric analysis of single cells. Applications of standard flow cytometry include identification of cell types based on lineage markers, quantitative expression of membrane-bound and intracellular molecules, and analysis of cell status and function. The multi-parametric power of flow cytometry mostly derives from the ability to collect and differentiate multiple fluorophores. Depending on the number of lasers, detectors and filter combinations, the most recent configurations of commercially available flow cytometers can discriminate more than 30 different emitting fluorophores (<xref ref-type="bibr" rid="B177">177</xref>&#x2013;<xref ref-type="bibr" rid="B179">179</xref>). Flow cytometers can detect cells and particles within 0.2-150 &#x3bc;m in diameter, although the use specialized systems can allow the detection outside this range.</p>
<p>Flow cytometry is frequently applied to spheroid research as end-point assay to quantify NK cell infiltration, characterize the viability, proliferation and phenotype of NK cells and tumor cells isolated from spheroid cultures, and to analyze functional parameters, such as degranulation and cytokine production of spheroid-infiltrating NK cells. A strategy to separate spheroid-infiltrating NK cells from extra-tumoral NK cells is to collect the culture supernatant (extra-tumoral NK cell fraction) and the spheroid mass (spheroid-infiltrating NK cell fraction) in different tubes prior to tissue processing and immunostaining (<xref ref-type="bibr" rid="B106">106</xref>, <xref ref-type="bibr" rid="B112">112</xref>, <xref ref-type="bibr" rid="B119">119</xref>, <xref ref-type="bibr" rid="B180">180</xref>). Flow cytometry analysis of the two fractions showed enrichment of NK cells and CD8<sup>+</sup> T cells in the spheroid core (<xref ref-type="bibr" rid="B112">112</xref>, <xref ref-type="bibr" rid="B119">119</xref>), demonstrating a better infiltrative ability of these two populations compared to CD4<sup>+</sup> T cells, further enhanced by IL-15 activation (<xref ref-type="bibr" rid="B119">119</xref>).</p>
<p>Similar to what has been observed in tumor patients (<xref ref-type="bibr" rid="B118">118</xref>), spheroid-infiltrating NK cells tend to lose the expression of NKG2D and DNAM-1 (<xref ref-type="bibr" rid="B119">119</xref>, <xref ref-type="bibr" rid="B124">124</xref>). NK2GD expression could be partially restored by blocking MICA/B, contributing to better NK cell cytotoxicity and infiltration (<xref ref-type="bibr" rid="B119">119</xref>). The levels of soluble NKG2D ligands are high in the plasma obtained from tumor patients, and their levels tend to decrease after surgery, further proving their implication in cancer progression. In line with that, Giannattasio et&#xa0;al. showed abundant shedding of NKG2D ligands in cervical carcinoma spheroids, associated with decreased expression of the membrane-bound form (<xref ref-type="bibr" rid="B106">106</xref>). Increased HLA class I expression has also been observed in tumor spheroids compared to monolayer cultures (<xref ref-type="bibr" rid="B181">181</xref>).</p>
<p>NK cell cytotoxicity can be analyzed by flow cytometry calculating the percentage of dead tumor cells, identified with apoptotic markers and/or cell impermeant dyes. Combinatorial staining with Annexin V and 7-AAD or propidium iodine staining is frequently used to quantify early and late apoptosis of spheroid-derived tumor cells and NK cells (<xref ref-type="bibr" rid="B119">119</xref>, <xref ref-type="bibr" rid="B125">125</xref>, <xref ref-type="bibr" rid="B180">180</xref>, <xref ref-type="bibr" rid="B182">182</xref>, <xref ref-type="bibr" rid="B183">183</xref>). Veneziani et&#xa0;al. performed flow cytometry analysis of patient-derived neuroblastoma spheroids co-cultured with NK cells and Nutlin-3, characterizing the phenotype of NK cells together with the apoptotic state of tumor cells. They demonstrated up-regulation of ULBPs, PVR and Nectin-2 on Nutlin-3-treated tumor cells, associated with increased NK cell cytotoxicity (<xref ref-type="bibr" rid="B183">183</xref>). NK cell functionality can also be inferred by qualitative and quantitative assessment of cytokine production and granule content (IFN-&#x3b3;, TNF-&#x3b1;, MIP-1&#x3b1;, perforin, granzyme B) and granule release (CD107a).</p>
<p>The main advantage of flow cytometry is the multi-parametric analysis of single cells at high-throughput. Despite the considerable amount of information that can be retrieved, flow cytometry lacks spatial and temporal resolution. Additionally, it can introduce technical artifacts. Such risk can be reduced by using mild dissociation agents and decreasing the time between the dissociation and the flow cytometry acquisition. NK cell killing over time can only assessed by preparing multiple NK-tumor co-cultures and analyzing them at different timepoints, with technical variability affecting the robustness of the assay. Therefore, it would be preferable to use flow cytometry for a single-timepoint experiment and move to other techniques when spatial information and dynamics are part of the biological question.</p>
</sec>
<sec id="s4_3">
<label>4.3</label>
<title>Measuring NK cell cytotoxicity by detecting spheroid physical changes</title>
<p>NK cell activity can cause variations of the spheroid physical properties, such as diameter, volume, and weight, which can be detected and quantified to estimate NK cell-mediated spheroid killing (<xref ref-type="bibr" rid="B117">117</xref>, <xref ref-type="bibr" rid="B119">119</xref>, <xref ref-type="bibr" rid="B127">127</xref>, <xref ref-type="bibr" rid="B142">142</xref>, <xref ref-type="bibr" rid="B183">183</xref>). Rademacher et&#xa0;al. monitored the diameter of sarcoma spheroids over time by widefield microscopy to study the effect of IL-12 on NK92 cytotoxicity and infiltration. They detected a reduction of spheroid diameter incubating NK92 cells with IL-12-engireed osteosarcoma cells, suggesting a positive effect of IL-12 on NK cell activity in 3D (<xref ref-type="bibr" rid="B127">127</xref>). Similarly, the reduction of spheroid volume was used to evaluate the benefits of cytokine activation on PBMC cytotoxicity against heterotypic and homotypic colorectal cancer spheroids (<xref ref-type="bibr" rid="B119">119</xref>, <xref ref-type="bibr" rid="B142">142</xref>). Sargenti et&#xa0;al. developed a fluidic platform to estimate NK cell cytotoxicity and infiltration measuring spheroid weight and diameter (<xref ref-type="bibr" rid="B117">117</xref>). The method is based on tracking the motion of spheroids falling into a vertical flow channel using a brightfield imaging system (<xref ref-type="bibr" rid="B117">117</xref>, <xref ref-type="bibr" rid="B184">184</xref>). Analyzing spheroids obtained from four different colorectal tumor cell lines, the authors were able to correlate the mass density with the degree of spheroid compactness (<xref ref-type="bibr" rid="B117">117</xref>). Co-incubation with NK cells led to a significant reduction of spheroid weight and diameter, while a temporary increase of spheroid mass density was associated to NK cell infiltration (<xref ref-type="bibr" rid="B117">117</xref>). There are reports saying that spheroid volume does not affect NK cytotoxicity (<xref ref-type="bibr" rid="B97">97</xref>, <xref ref-type="bibr" rid="B115">115</xref>), while spheroid cellular density and compactness do (<xref ref-type="bibr" rid="B115">115</xref>, <xref ref-type="bibr" rid="B117">117</xref>). The analysis of spheroid physical properties represents a fast, non-invasive and easily accessible method to measure NK cell cytotoxicity. However, its application is arguably limited, due to lack of sensitivity and information. During early phases of NK killing, spheroids often get partly disintegrated and less compact, leading to increased volume which may seem contradictory. In addition, NK cell infiltration itself might induce volume and mass changes, which are difficult to isolate and subtract from the quantification. The method itself does not provide information regarding the mechanisms of NK cell killing and spheroid death. To overcome these limitations, the study of spheroid physical properties is usually combined with histological characterization and other cell labeling-based quantitative analysis.</p>
</sec>
<sec id="s4_4">
<label>4.4</label>
<title>Measuring NK cell cytotoxicity and infiltration by detecting spheroid histological changes</title>
<p>A method to characterize NK cell cytotoxicity and infiltration in the spheroids is by performing histochemical staining of sections. Various histological changes have been associated with NK cell activity in tumor spheroids, such as loss of surface integrity (<xref ref-type="bibr" rid="B98">98</xref>, <xref ref-type="bibr" rid="B115">115</xref>), formation of cytoplasmic blebs, chromatin condensation (<xref ref-type="bibr" rid="B111">111</xref>, <xref ref-type="bibr" rid="B116">116</xref>) and mitochondrial swelling (<xref ref-type="bibr" rid="B98">98</xref>). Simply using immunostaining and haematoxylin/eosin counterstaining, Kaaijk et&#xa0;al. described two modalities of LAK killing in glioma spheroids: a) apoptosis, characterized by loss of cell volume, chromatin condensation and formation and apoptotic bodies; b) necrosis, identified by loss of fibrillary structure and acquisition of smooth appearance in the cytoplasm, loss of membrane integrity and swollen nuclei (<xref ref-type="bibr" rid="B116">116</xref>). Studying the relative position of LAK and dead glioma cells in spheroid tissue sections, J&#xe4;&#xe4;skel&#xe4;inen et&#xa0;al. localized tumor cell death in areas devoid of LAK infiltration, speculating that contact-independent killing modalities mediated by soluble factors could play a role (<xref ref-type="bibr" rid="B111">111</xref>). Contact-mediated killing has been demonstrated by Iwasaki et&#xa0;al. imaging ultrathin spheroid sections by transmission electron microscopy (<xref ref-type="bibr" rid="B98">98</xref>). Using this technique, the authors captured the formation of tight cytoplasmic interdigitations between effector and target cells in the spheroid core, and the development of intracytoplasmatic dense granules that usually precedes degranulation (<xref ref-type="bibr" rid="B98">98</xref>).</p>
<p>To introduce the temporal factor, it is possible to collect and stain spheroids at different times, to follow the progressive infiltration and cytotoxicity of NK cells toward the core (<xref ref-type="bibr" rid="B98">98</xref>, <xref ref-type="bibr" rid="B112">112</xref>, <xref ref-type="bibr" rid="B115">115</xref>). To quantify this behavior, there have been multiple attempts to classify NK cell infiltration or/and spheroid death (<xref ref-type="bibr" rid="B98">98</xref>, <xref ref-type="bibr" rid="B105">105</xref>). For instance, J&#xe4;&#xe4;skel&#xe4;inen et&#xa0;al. calculated the density of LAK cells in three different spheroid areas, corresponding to the periphery (100 &#x3bc;m depth from the spheroid surface), the intermediate layer (100 &#x3bc;m to 200 &#x3bc;m depth) and the core (200 &#x3bc;m to 300 &#x3bc;m depth) to quantify the involvement of adhesion molecules on LAK infiltration. According to their findings, the expression of adhesion molecules varied in the different areas and it was strongly influenced by the secretory activity of LAK cells. For instance, the levels of CD54 were weak in periphery of glioma spheroids and intense in the intermediate rim in the absence of LAK cells, while the expression intensified along the frontier of migrating cells possibly due to IFN-&#x3b3; release. Blocking CD54 completely prevented LAK migration into the spheroids, showing the relevance of this pathway for NK infiltration (<xref ref-type="bibr" rid="B112">112</xref>).</p>
<p>Iwasaki et&#xa0;al. classified the activity of LAK cells into four categories based on both infiltration and cell damage: grade I) effectors in contact with the spheroid surface and little target death; grade II) effector infiltration into the outer third layer of the spheroid accompanied by target cell death; grade III) target death detected in the middle layer of the spheroid; grade IV) target death detected in the core of the spheroid (<xref ref-type="bibr" rid="B98">98</xref>). Garcia de Palazzo et&#xa0;al. developed a similar system to classify the histological changes of colon cancer spheroids and quantify the effect of CA19-9-CD16 bispecific antibody on LAK 3D killing (<xref ref-type="bibr" rid="B105">105</xref>). Based on haematoxylin/eosin staining, they classified the histological damage into five grades calculating the percentage of necrosis in relation to the control condition (<xref ref-type="bibr" rid="B105">105</xref>).</p>
<p>Histochemistry can be also applied for the analysis of NK cell status in the TME. For instance, Weil et&#xa0;al. detected apoptotic NK cells in the core of head and neck squamous cell carcinoma spheroids following soluble MICA exposure (<xref ref-type="bibr" rid="B118">118</xref>), demonstrating the detrimental effect of soluble NKG2D ligands on NK cell-mediated tumor surveillance (<xref ref-type="bibr" rid="B118">118</xref>, <xref ref-type="bibr" rid="B185">185</xref>).</p>
<p>Despite these efforts, the use of spheroid morphological changes to quantify NK cytotoxicity remains problematic, suffering from subjective evaluation and lack of universal classification. Lack of three-dimensionality and time resolution represent additional limitations. Tissue reconstruction could retrieve 3D spatial information, but it is technically difficult and rarely performed. The kinetics of NK cytotoxicity can be studied performing time-course assays on spheroid replicates, however limited time resolution (usually day-scale) and sample availability makes live cell imaging a preferred option, which is also compatible with cell tracking. Despite these limitations, histological analysis is considered a valuable and very informative option as end-point assays and qualitative analysis, especially to confirm data obtained by other techniques (<xref ref-type="bibr" rid="B119">119</xref>, <xref ref-type="bibr" rid="B135">135</xref>). The recent development in the field, such as the release of methodology and machines for automated multiplexed staining and analysis (e.g. Hyperion, MACSima, CODEX), will most likely increase the use of this technique to NK cell and spheroid studies.</p>
</sec>
<sec id="s4_5">
<label>4.5</label>
<title>Measuring NK cell cytotoxicity and infiltration using fluorescence microscopy</title>
<p>A variety of fluorescent dyes have been developed to characterize cell status, such as viability, apoptosis, necrosis, proliferation, and metabolism. If properly chosen, these markers can provide information on the killing modality. For this reason, coupling cell labeling with fluorescence-based imaging techniques is a particularly suitable strategy to characterize NK cell cytotoxicity in tumor spheroids.</p>
<p>The workflow involves cell labeling before, during, or at the end of the cytotoxicity assay, and detection by the appropriate microscopes, such as widefield, confocal, light sheet or two-photon fluorescence microscopes. The variation of the fluorescence intensity during NK-spheroid co-cultures can be quantified, such as loss of viability and proliferation markers, or acquisition of necrotic/apoptotic markers, providing an unbiased evaluation of NK cell activity. In addition, live cell imaging can be performed to study the kinetic of spheroid death and NK cell infiltration with good temporal resolution.</p>
<p>Giannattasio et&#xa0;al. followed the infiltration of Hoechst-labeled NK cells into CFSE-labeled cervical carcinoma spheroids for 48 hours with 30 minutes time resolution using widefield fluorescence microscopy, showing NK cell proliferation and accumulation at the periphery of the spheroids (<xref ref-type="bibr" rid="B106">106</xref>). To characterize the spheroid inner areas, imaging techniques with 3D resolution, such as confocal, light sheet and two-photon microscopy, can be easier than sectioning. These techniques provide spatial information of NK cell infiltration and killing while preserving sample integrity. An additional benefit is low sample consumption, as time courses and 3D characterization can be performed simultaneously on a single sample. Imaging a single focal plane inside the breast cancer spheroids with 30 second resolution, Ayuso et&#xa0;al. tracked NK92 chemotaxis towards the spheroid core (<xref ref-type="bibr" rid="B92">92</xref>). Using this strategy, they were able to describe the directionality and the modality of NK cell migration, capturing NK cell bodies squeezing between tumor cell junctions to reach the inner areas of the spheroid (<xref ref-type="bibr" rid="B92">92</xref>). They quantified NK cell infiltration and spheroid killing, showing that increasing effector-to-target ratios positively influenced NK cell ability to kill multiple spheroid layers (<xref ref-type="bibr" rid="B92">92</xref>, <xref ref-type="bibr" rid="B106">106</xref>, <xref ref-type="bibr" rid="B123">123</xref>, <xref ref-type="bibr" rid="B135">135</xref>).</p>
<p>Hoogstad-van Evert et&#xa0;al. analyzed the activity of hematopoietic stem and progenitor cells (HSPC)-NK cells on ovarian cancer spheroids using a similar approach (<xref ref-type="bibr" rid="B123">123</xref>). They performed live cell confocal imaging on a single focal plane to study the dynamics of HSPC-NK cell cytotoxicity over five hours. As an end-point assay, they imaged multiple focal planes to collect data from a 60 &#x3bc;m spheroid section, which allowed them to quantify dead tumor cells in relation to tissue depth (<xref ref-type="bibr" rid="B123">123</xref>).</p>
<p>
<italic>In vitro</italic>, NK cell killing of tumor cell suspensions manifests within a few minutes from stimulation, and it persists for few days before NK exhaustion and/or dysfunctionality occurs. The killing mechanisms can shift over time, as well as tumor cells susceptibility. For these reasons, long-term assays are usually considered particularly appropriate for the characterization of NK cell killing modalities. The duration of the assay is particularly important in 3D, where the infiltration of NK cells and the diffusion of soluble factors influence the killing dynamics. Phototoxicity and photostability are two important parameters to take into consideration while performing long-term imaging assays, as both could introduce technical artifacts and reduce the test sensitivity. For these reasons, internal controls should always be run to test the phototoxicity levels, and dyes resistant to photobleaching and cell-mediated degradation are recommended. If phototoxicity and photostability are properly addressed, long-term imaging assays could be very informative.</p>
<p>Our own time-course analysis revealed high inter-donor heterogeneity in terms of killing dynamics, and it predicted donor-specific long-term and short-term response to combinatorial treatment <italic>in vitro</italic> (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>) (<xref ref-type="bibr" rid="B156">156</xref>, <xref ref-type="bibr" rid="B186">186</xref>). We tracked NK cell-mediated cytotoxicity of renal and ovarian cancer spheroids for three days combining the use of two fluorescent dyes: a mitochondrial activity reporter (TMRM) as viability marker, and a caspase-3/7 activity reporter as apoptotic marker (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). As expected, NK cell activity induced a cumulative loss of spheroid viability over time (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4A, B</bold>
</xref>). However, a detailed characterization of the time-courses showed high variation in killing dynamics and long-term response to combinatorial therapy among NK donors. In the same assay, the analysis of caspase-3/7 intensity curves revealed the time of maximum NK cell-mediated apoptotic death, corresponding to the peak of fluorescent intensity. In addition, the combined used of two dyes allowed us to normalize the amount of apoptotic death for the initial spheroid viability, providing a more sensitive parameter for comparing different spheroid types (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>). Thanks to the long-term stability of the dyes, we were able to perform 3D confocal microscopy at the end of the live imaging assays to localize tumor cell apoptosis (<xref ref-type="bibr" rid="B156">156</xref>). Knowing when NK cell populations reach their maximum activity could be valuable information for designing personalized combinatorial therapy. It could also reveal the presence of different NK populations active at different times.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Dynamics of NK cell cytotoxicity against tumor spheroids. IL-15 activated NK cells were incubated with pre-formed renal carcinoma spheroids and imaged for 72 hours. <bold>(A)</bold> Time-lapse sequence of NK cell killing of renal carcinoma spheroids analyzed by live imaging. TMRM (in magenta) and a caspase-3/7 activity reporter (in green) were used to detect spheroid viability and apoptosis, respectively. NK cells can be seen in the brightfield channel. Scale bar: 100 &#x3bc;m. <bold>(B, C)</bold> Time-course of spheroid viability <bold>(B)</bold> and apoptotic index <bold>(C)</bold> from a single microwell chip chamber (n=36). The data were presented in Carannante et&#xa0;al. (<xref ref-type="bibr" rid="B186">186</xref>).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1135148-g004.tif"/>
</fig>
<p>Courau et&#xa0;al. combined long-term live imaging with flow cytometric end-point analysis to study the contribution of each PBMC population to spheroid cytotoxicity and infiltration (<xref ref-type="bibr" rid="B119">119</xref>). They observed infiltration and killing of colorectal cancer spheroids under IL-15 exposure, mainly driven by NK and CD8<sup>+</sup> T cells. The presence of activated PBMCs induced HLA-expression on tumor spheroids, while infiltrated NK cells showed a reduction of NKG2D expression. Coupling anti-MICA/B antibody with anti-NKG2A checkpoint blockade enhanced spheroid apoptosis and PBMC infiltration (<xref ref-type="bibr" rid="B119">119</xref>).</p>
<p>If multiple set of assays are planned, it is a common practice to genetically modify tumor cells to stably express fluorescent proteins (<xref ref-type="bibr" rid="B120">120</xref>, <xref ref-type="bibr" rid="B123">123</xref>, <xref ref-type="bibr" rid="B125">125</xref>, <xref ref-type="bibr" rid="B135">135</xref>, <xref ref-type="bibr" rid="B144">144</xref>, <xref ref-type="bibr" rid="B180">180</xref>, <xref ref-type="bibr" rid="B187">187</xref>). This strategy allows direct assessment of spheroid viability by measuring the variation of fluorescence intensity, removing the need of additional staining steps. For instance, Susek et&#xa0;al. applied this strategy to study the efficacy of chimeric switch receptors (CSR) for cell-based immunotherapy (<xref ref-type="bibr" rid="B120">120</xref>). To revert PD-1-mediated NK cell inhibition, they designed a PD-1-CSR replacing the inhibitory intracellular domains of PD-1 with activating motifs. They quantified the activity of PD-1-CSR NK-92 cells against renal carcinoma spheroids expressing red fluorescent protein by live imaging, demonstrating good specificity and cytotoxic activity of the cell product (<xref ref-type="bibr" rid="B120">120</xref>). Lanuza et&#xa0;al. used EGFP-transfected colorectal carcinoma cells to facilitate the detection of the spheroid area, used to quantify the cytotoxic effect of different effector-to-target ratios over time (<xref ref-type="bibr" rid="B135">135</xref>).</p>
<p>We used GFP-transfected NK92 to visualize the formation effector-to-target cell contacts in renal carcinoma spheroids using light sheet microscopy (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>) (<xref ref-type="bibr" rid="B188">188</xref>). S&#xe4;rchen et&#xa0;al. combined the use of fluorescently labeled proteins with cell death markers to calculate spheroid killing as the ratio between the two parameters, allowing a fair comparison between spheroids heterogeneous in size. Using this method, they showed the positive effects of BH3 mimetics on NK cell killing of pediatric cancer spheroids (<xref ref-type="bibr" rid="B187">187</xref>). Cell transfection with fluorescent proteins presents multiple advantages, such as reducing the optimization steps and facilitating the analysis. However, this approach is not suitable for all types of cells and applications since the transfection efficiency varies among cell types, with some being very resistant to genetic modifications, and cell manipulation is not compatible with the characterization of primary tumor samples, such as patient-derived tumor spheroids, since it might cause loss of the original sample features.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Visualization of spheroid-infiltrating NK cells by light sheet microscopy and confocal microscopy. <bold>(A)</bold> Light sheet microscopy image showing NK92 cells (yellow) infiltrating a renal carcinoma spheroid (magenta). RFP<sup>+</sup> A498 renal carcinoma spheroids were incubated with GFP<sup>+</sup> NK92 cells for 2 hours before undergoing tissue expansion in deionized water and imaged by light sheet microscopy. <bold>(B)</bold> YFP<sup>+</sup> A498 renal carcinoma spheroids were incubated with resting NK for 48 hours before being imaged by confocal microscopy. NK cells were detected in both extra-tumoral and intra-tumoral areas. However, the signal was progressively lost at increased depth. Left panel: 3D rendered confocal stack of an A498 renal carcinoma spheroid (magenta) co-cultured with NK cells (yellow). Central panel: optical section of the spheroid showed in the left panel (z = 30 &#x3bc;m). Central panel: optical section of the spheroid showed in the left panel (z = 60 &#x3bc;m).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1135148-g005.tif"/>
</fig>
<p>Apart from choosing the right labeling strategy, phototoxicity and photostability could be minimized by choosing microscopy techniques particularly suited for live 3D imaging, such as light sheet microscopy instead of confocal microscopy (<xref ref-type="bibr" rid="B189">189</xref>). Confocal microscopes involve a single objective for both illumination and detection, and 3D resolution is achieved generating signal from out-of-focus planes, which is then filtered out to detect the focal plane of interest. This design leads to relatively high photobleaching and phototoxicity, while sacrificing fluorescent signal to achieve optical sectioning. However, smaller spheroids can be imaged live with good results by confocal microscopy for a limited time, for instance to quantify NK cell infiltration (see example in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>). In light sheet microscopes, two separate objectives are used for illuminating the sample and detecting the signal. The illumination objective focuses a sheet of light to the plane of interest, and the detection objective collects light from the excited focal plane. Using this design, only the focal plane of interest is illuminated, causing little photobleaching and phototoxicity. Since the whole focal plane is imaged, the acquisition is dramatically faster than point-scanning confocal imaging (<xref ref-type="bibr" rid="B190">190</xref>, <xref ref-type="bibr" rid="B191">191</xref>). These features make light sheet microscopy particularly suitable for imaging fast biological events in thick samples, such as cell division and NK cell infiltration in tumor spheroids (<xref ref-type="bibr" rid="B192">192</xref>). Thick samples scattering large amount of light can be imaged using multi-view acquisition, i.e., imaging the sample from multiple angles and combining the information during post-processing (<xref ref-type="bibr" rid="B190">190</xref>). This feature has been used by Del Bano et&#xa0;al. to study the effect of anti-mesothelin/CD16 bispecific antibody on NK cell infiltration in triple negative breast cancer spheroids (<xref ref-type="bibr" rid="B109">109</xref>). We combined cell transfection with fluorescent proteins, light sheet microscopy and tissue expansion to achieve detailed visualization of spheroid-infiltrating NK cells (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>) (<xref ref-type="bibr" rid="B188">188</xref>). Specifically, RFP<sup>+</sup> renal carcinoma spheroids were incubated with GFP<sup>+</sup> NK92 cells for 2 hours before undergoing tissue expansion and light sheet microscopy imaging. This technique is suitable for imaging the details of NK cell interactions with tumor cells in thick samples (<xref ref-type="bibr" rid="B188">188</xref>), for instance to obtain snapshots of killing mechanisms, metabolic activity, or receptor modulation. Like every technique, also light sheet microscopy presents its own disadvantages. The sample is commonly embedded in hydrogel, and some embedding media are not compatible with all cell types. The embedding procedure can be quite laborious, it can affect sample viability, and it is not compatible with high-throughput analysis. Finally, a typical light sheet microscopy experiment generates large amount of data, which are time consuming to transfer and process, and require high computational and storage capacity.</p>
</sec>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusions</title>
<p>Since immunotherapy became a standard clinical practice, multiple cases of innate and acquired resistance have been reported, pointing out that more research is needed to understand the mechanisms of immunosuppression and to predict individual responses to treatment. To gain more knowledge, we need robust <italic>in vitro</italic> systems suitable for immuno-oncology studies. The characterization of NK cells in the original tumor tissues is challenging due to limited infiltration and tumor-driven changes in their phenotype (<xref ref-type="bibr" rid="B193">193</xref>). 3D cultures represent a fantastic tool to overcome these issues. The application spans from identifying the reasons behind poor NK cell performance in solid tumors, to developing and testing new strategies to boost their activity. The 3D platforms currently available allow analysis of cell phenotype, spatial distribution, and function. Phenotype, localization, and function can be analyzed at different levels, from gene expression to cell morphology and dynamics. Despite the broad range of characterization that they allow, their full potential is rarely exploited. In NK cell research, tumor spheroids are still mainly used as &#x201c;support assays&#x201d; to confirm data obtained from 2D assays or <italic>in vivo</italic>. The main application remains testing NK cells in combination with other therapies, most of the time without providing a full characterization of neither NK cells nor tumor spheroids. It is not rare to find qualitative data of NK cell infiltration and killing with no quantification provided. The main challenges are to obtain high-throughput, high-quality and quantitative imaging, as well as biologically relevant models of the solid tumor microenvironment. In this regard, rigorous validation of the model should be performed by comparing the 3D architecture and the cellular composition of the original tissue with the <italic>in vitro</italic> 3D culture, following its evolution over time. This is particularly important for NK cell research, considering the impact that tissue architecture, cellular and extracellular composition has on immune cell migration and cytotoxic capability. More developed use of 3D cultures combined with automated analysis pipelines, perhaps artificial intelligence-driven, could expand their application to NK cell mechanistic studies and quantitative analysis. Still, more research is needed to fully understand and exploit the possibilities that 3D cultures can offer.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author contributions</title>
<p>VC and B&#xd6; drafted the content of the manuscript. VC wrote the first draft of the manuscript that was edited by to its final form by VC, MW, and B&#xd6;. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="s7" sec-type="funding-information">
<title>Funding</title>
<p>We thank The Knut and Alice Wallenberg Foundation (Grant No 2018.0106), The Swedish Research Council (Grant No 2019-04925), The Swedish Foundation for Strategic Research (Grant No SBE13-0092), The Swedish Childhood Cancer Foundation (Grant No MT2019-0022), The Swedish Cancer Foundation (Grant No 19 0540 Pj) for financial support.</p>
</sec>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<fn-group>
<title>Abbreviations</title>
<fn fn-type="abbr">
<p>3D, three-dimensional; NK, natural killer; TME, tumor microenvironment; 2D, two-dimensional; PDMS, polydimethylsiloxane; ECM, extracellular matrix; iPS, induced pluripotent stem cells; PBMC, peripheral blood mononuclear cell; IFN, interferon; TNF, tumor necrosis factor; IL, interleukin; ADCC, antibody-depended cellular cytotoxicity; dNK, decidual NK; IP, interferon-inducible protein; HSC, hepatic stellate cells; DC, dentric cell; CAR, chimeric antigen receptor; TGF, transforming growth factor; LAK, lymphokine-activated killer cells; poly-HEMA, poly-2-hydroxyethyl methylacrylate; ULA, ultra-low attachment; PEG, polyethylene glycol; UCB, umbilical cord blood; USW, ultrasonic standing waves; <sup>51</sup>Cr, chromium-51; LDH, lactate dehydrogenase (LDH); PLGA-MnO<sub>2</sub> NPs, poly(lactic-co-glycolic) manganese dioxide nanoparticles; HSPC, hematopoietic stem and progenitor cells; CSR, chimeric switch receptors.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooper</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Fehniger</surname> <given-names>TA</given-names>
</name>
<name>
<surname>Caligiuri</surname> <given-names>MA</given-names>
</name>
</person-group>. <article-title>The biology of human natural killer-cell subsets</article-title>. <source>Trends Immunol</source> (<year>2001</year>) <volume>22</volume>:<page-range>633&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1471-4906(01)02060-9</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>JN</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Ryan</surname> <given-names>D</given-names>
</name>
<name>
<surname>Whitesides</surname> <given-names>GM</given-names>
</name>
</person-group>. <article-title>Compatibility of mammalian cells on surfaces of poly(dimethylsiloxane)</article-title>. <source>Langmuir</source> (<year>2004</year>) <volume>20</volume>:<page-range>11684&#x2013;91</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/la048562+</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname> <given-names>X</given-names>
</name>
<name>
<surname>Young</surname> <given-names>EWK</given-names>
</name>
<name>
<surname>Underkofler</surname> <given-names>HAS</given-names>
</name>
<name>
<surname>Kamp</surname> <given-names>TJ</given-names>
</name>
<name>
<surname>January</surname> <given-names>CT</given-names>
</name>
<name>
<surname>Beebe</surname> <given-names>DJ</given-names>
</name>
</person-group>. <article-title>Microfluidic cell culture and its application in high-throughput drug screening: cardiotoxicity assay for hERG channels</article-title>. <source>J Biomol Screen</source> (<year>2011</year>) <volume>16</volume>:<page-range>101&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/1087057110386218</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname> <given-names>C-W</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>J-Y</given-names>
</name>
<name>
<surname>Young</surname> <given-names>T-H</given-names>
</name>
</person-group>. <article-title>Elucidating <italic>in vitro</italic> cell-cell interaction using a microfluidic coculture system</article-title>. <source>BioMed Microdevices</source> (<year>2006</year>) <volume>8</volume>:<fpage>65</fpage>&#x2013;<lpage>71</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10544-006-6384-8</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname> <given-names>C-W</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>Y-J</given-names>
</name>
<name>
<surname>Tu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y-H</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>C-C</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>W-H</given-names>
</name>
<etal/>
</person-group>. <article-title>A polydimethylsiloxane&#x2013;polycarbonate hybrid microfluidic device capable of generating perpendicular chemical and oxygen gradients for cell culture studies</article-title>. <source>Lab Chip</source> (<year>2014</year>) <volume>14</volume>:<page-range>3762&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/C4LC00732H</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez-Moreno</surname> <given-names>M</given-names>
</name>
<name>
<surname>Jamora</surname> <given-names>C</given-names>
</name>
<name>
<surname>Fuchs</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Sticky business: orchestrating cellular signals at adherens junctions</article-title>. <source>Cell</source> (<year>2003</year>) <volume>112</volume>:<page-range>535&#x2013;48</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0092-8674(03)00108-9</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Kusindarta</surname> <given-names>DL</given-names>
</name>
</person-group>. <article-title>The role of extracellular matrix</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Kaoud HWE-HA hay</surname> <given-names>E-S</given-names>
</name>
</person-group> editor. <source>Tissue Regeneration</source> Chapter 5. <publisher-loc>Rijeka</publisher-loc>: <publisher-name>IntechOpen</publisher-name> (<year>2018</year>). doi:&#xa0;<pub-id pub-id-type="doi">10.5772/intechopen.75728</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Altman</surname> <given-names>GH</given-names>
</name>
<name>
<surname>Horan</surname> <given-names>RL</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>I</given-names>
</name>
<name>
<surname>Farhadi</surname> <given-names>J</given-names>
</name>
<name>
<surname>Stark</surname> <given-names>PRH</given-names>
</name>
<name>
<surname>Volloch</surname> <given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Cell differentiation by mechanical stress</article-title>. <source>FASEB J</source> (<year>2002</year>) <volume>16</volume>:<page-range>270&#x2013;2</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1096/fj.01-0656fje</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poltavets</surname> <given-names>V</given-names>
</name>
<name>
<surname>Kochetkova</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pitson</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Samuel</surname> <given-names>MS</given-names>
</name>
</person-group>. <article-title>The role of the extracellular matrix and its molecular and cellular regulators in cancer cell plasticity</article-title>. <source>Front Oncol</source> (<year>2018</year>) <volume>8</volume>:<elocation-id>431</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fonc.2018.00431</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koohestani</surname> <given-names>F</given-names>
</name>
<name>
<surname>Braundmeier</surname> <given-names>AG</given-names>
</name>
<name>
<surname>Mahdian</surname> <given-names>A</given-names>
</name>
<name>
<surname>Seo</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bi</surname> <given-names>J</given-names>
</name>
<name>
<surname>Nowak</surname> <given-names>RA</given-names>
</name>
</person-group>. <article-title>Extracellular matrix collagen alters cell proliferation and cell cycle progression of human uterine leiomyoma smooth muscle cells</article-title>. <source>PloS One</source> (<year>2013</year>) <volume>8</volume>:<page-range>e75844&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0075844</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>L&#xf3;pez-Mart&#xed;nez</surname> <given-names>C</given-names>
</name>
<name>
<surname>Huidobro</surname> <given-names>C</given-names>
</name>
<name>
<surname>Albaiceta</surname> <given-names>GM</given-names>
</name>
<name>
<surname>L&#xf3;pez-Alonso</surname> <given-names>I</given-names>
</name>
</person-group>. <article-title>Mechanical stretch modulates cell migration in the lungs</article-title>. <source>Ann Transl Med</source> (<year>2018</year>) <volume>6</volume>:<fpage>28</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.21037/atm.2017.12.08</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mason</surname> <given-names>EF</given-names>
</name>
<name>
<surname>Rathmell</surname> <given-names>JC</given-names>
</name>
</person-group>. <article-title>Cell metabolism: an essential link between cell growth and apoptosis</article-title>. <source>Biochim Biophys Acta (BBA) - Mol Cell Res</source> (<year>2011</year>) <volume>1813</volume>:<page-range>645&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbamcr.2010.08.011</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clanton</surname> <given-names>TL</given-names>
</name>
<name>
<surname>Hogan</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Gladden</surname> <given-names>LB</given-names>
</name>
</person-group>. <article-title>Regulation of cellular gas exchange, oxygen sensing, and metabolic control</article-title>. <source>Compr Physiol</source> (<year>2013</year>) <volume>13</volume>(<issue>3</issue>):<page-range>1135&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/cphy.c120030</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>X</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Oxygen-induced cell migration and on-line monitoring biomarkers modulation of cervical cancers on a microfluidic system</article-title>. <source>Sci Rep</source> (<year>2015</year>) <volume>5</volume>:<elocation-id>9643</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/srep09643</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petrie Aronin</surname> <given-names>CE</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>YM</given-names>
</name>
<name>
<surname>Yoon</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Morgan</surname> <given-names>NY</given-names>
</name>
<name>
<surname>Pr&#xfc;stel</surname> <given-names>T</given-names>
</name>
<name>
<surname>Germain</surname> <given-names>RN</given-names>
</name>
<etal/>
</person-group>. <article-title>Migrating myeloid cells sense temporal dynamics of chemoattractant concentrations</article-title>. <source>Immunity</source> (<year>2017</year>) <volume>47</volume>:<fpage>862</fpage>&#x2013;<lpage>874.e3</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2017.10.020</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stojanovic</surname> <given-names>A</given-names>
</name>
<name>
<surname>Correia</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Cerwenka</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Shaping of NK cell responses by the tumor microenvironment</article-title>. <source>Cancer Microenviron</source> (<year>2013</year>) <volume>6</volume>:<page-range>135&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12307-012-0125-8</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balkwill</surname> <given-names>FR</given-names>
</name>
<name>
<surname>Capasso</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hagemann</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>The tumor microenvironment at a glance</article-title>. <source>J Cell Sci</source> (<year>2012</year>) <volume>125</volume>:<page-range>5591&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1242/jcs.116392</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costa</surname> <given-names>EC</given-names>
</name>
<name>
<surname>Moreira</surname> <given-names>AF</given-names>
</name>
<name>
<surname>de Melo-Diogo</surname> <given-names>D</given-names>
</name>
<name>
<surname>Gaspar</surname> <given-names>VM</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Correia</surname> <given-names>IJ</given-names>
</name>
</person-group>. <article-title>3D tumor spheroids: an overview on the tools and techniques used for their analysis</article-title>. <source>Biotechnol Adv</source> (<year>2016</year>) <volume>34</volume>:<page-range>1427&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biotechadv.2016.11.002</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fennema</surname> <given-names>E</given-names>
</name>
<name>
<surname>Rivron</surname> <given-names>N</given-names>
</name>
<name>
<surname>Rouwkema</surname> <given-names>J</given-names>
</name>
<name>
<surname>van Blitterswijk</surname> <given-names>C</given-names>
</name>
<name>
<surname>de Boer</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Spheroid culture as a tool for creating 3D complex tissues</article-title>. <source>Trends Biotechnol</source> (<year>2013</year>) <volume>31</volume>:<page-range>108&#x2013;15</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tibtech.2012.12.003</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Zimmermann</surname> <given-names>M</given-names>
</name>
<name>
<surname>Box</surname> <given-names>C</given-names>
</name>
<name>
<surname>Eccles</surname> <given-names>SA</given-names>
</name>
</person-group>. <article-title>Two-dimensional vs. three-dimensional in vitro tumor migration and invasion assays</article-title>. In: <source>BMC systems biology</source>. <publisher-loc>Totowa, NJ</publisher-loc>: <publisher-name>Humana Press</publisher-name> (<year>2013</year>). p. <page-range>227&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-1-62703-311-4_15</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breslin</surname> <given-names>S</given-names>
</name>
<name>
<surname>O&#x2019;Driscoll</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Three-dimensional cell culture: the missing link in drug discovery</article-title>. <source>Drug Discovery Today</source> (<year>2013</year>) <volume>18</volume>:<page-range>240&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.drudis.2012.10.003</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergenheim</surname> <given-names>F</given-names>
</name>
<name>
<surname>Fregni</surname> <given-names>G</given-names>
</name>
<name>
<surname>Buchanan</surname> <given-names>CF</given-names>
</name>
<name>
<surname>Riis</surname> <given-names>LB</given-names>
</name>
<name>
<surname>Heulot</surname> <given-names>M</given-names>
</name>
<name>
<surname>Touati</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>A fully defined 3D matrix for ex vivo expansion of human colonic organoids from biopsy tissue</article-title>. <source>Biomaterials</source> (<year>2020</year>) <volume>262</volume>:<elocation-id>120248</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biomaterials.2020.120248</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Angres</surname> <given-names>BM</given-names>
</name>
<name>
<surname>Wurst</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>3-d life biomimetic hydrogels</article-title>. <source>Technol Platforms 3D Cell Culture</source> (<year>2017</year>), <fpage>197</fpage>&#x2013;<lpage>221</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/9781118851647.ch9</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleinman</surname> <given-names>HK</given-names>
</name>
<name>
<surname>McGarvey</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Hassell</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Star</surname> <given-names>VL</given-names>
</name>
<name>
<surname>Cannon</surname> <given-names>FB</given-names>
</name>
<name>
<surname>Laurie</surname> <given-names>GW</given-names>
</name>
<etal/>
</person-group>. <article-title>Basement membrane complexes with biological activity</article-title>. <source>Biochemistry</source> (<year>1986</year>) <volume>25</volume>:<page-range>312&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1021/bi00350a005</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Kleinman</surname> <given-names>HK</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>GR</given-names>
</name>
</person-group>. <article-title>Matrigel: basement membrane matrix with biological activity</article-title>. In: <source>Seminars in cancer biology</source>. <publisher-name>Elsevier</publisher-name> (<year>2005</year>) <volume>15</volume>(<issue>5</issue>):<page-range>378&#x2013;86</page-range>.</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caicedo-Carvajal</surname> <given-names>CE</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Remache</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Goy</surname> <given-names>A</given-names>
</name>
<name>
<surname>Suh</surname> <given-names>KS</given-names>
</name>
</person-group>. <article-title>Cancer tissue engineering: a novel 3D polystyrene scaffold for <italic>In vitro</italic> isolation and amplification of lymphoma cancer cells from heterogeneous cell mixtures</article-title>. <source>J Tissue Eng</source> (<year>2011</year>) <volume>2011</volume>:<elocation-id>362326</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.4061/2011/362326</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Spirio</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>PuraMatrix</article-title>. In: <source>Scaffolding in tissue engineering</source>. <publisher-name>CRC Press</publisher-name> (<year>2005</year>). p. <page-range>217&#x2013;38</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1201/9781420027563.ch15</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aisenbrey</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Murphy</surname> <given-names>WL</given-names>
</name>
</person-group>. <article-title>Synthetic alternatives to matrigel</article-title>. <source>Nat Rev Mater</source> (<year>2020</year>) <volume>5</volume>:<page-range>539&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41578-020-0199-8</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Carletti</surname> <given-names>E</given-names>
</name>
<name>
<surname>Motta</surname> <given-names>A</given-names>
</name>
<name>
<surname>Migliaresi</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Scaffolds for tissue engineering and 3D cell culture BT</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Haycock</surname> <given-names>JW</given-names>
</name>
</person-group>, editor. <source>3D cell culture: methods and protocols</source>. <publisher-loc>Totowa, NJ</publisher-loc>: <publisher-name>Humana Press</publisher-name> (<year>2011</year>). p. <fpage>17</fpage>&#x2013;<lpage>39</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-1-60761-984-0_2</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Souza</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Organoids</article-title>. <source>Nat Methods</source> (<year>2018</year>) <volume>15</volume>:<fpage>23</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nmeth.4576</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bar-Ephraim</surname> <given-names>YE</given-names>
</name>
<name>
<surname>Kretzschmar</surname> <given-names>K</given-names>
</name>
<name>
<surname>Clevers</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Organoids in immunological research</article-title>. <source>Nat Rev Immunol</source> (<year>2020</year>) <volume>20</volume>:<page-range>279&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41577-019-0248-y</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Artis</surname> <given-names>D</given-names>
</name>
<name>
<surname>Spits</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>The biology of innate lymphoid cells</article-title>. <source>Nature</source> (<year>2015</year>) <volume>517</volume>, <fpage>293</fpage>&#x2013;<lpage>301</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature14189</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiessling</surname> <given-names>R</given-names>
</name>
<name>
<surname>Klein</surname> <given-names>E</given-names>
</name>
<name>
<surname>Wigzell</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>&#x201c;Natural&#x201d; killer cells in the mouse. i. cytotoxic cells with specificity for mouse moloney leukemia cells. specificity and distribution according to genotype</article-title>. <source>Eur J Immunol</source> (<year>1975</year>) <volume>5</volume>:<page-range>112&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.1830050208</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiessling</surname> <given-names>R</given-names>
</name>
<name>
<surname>Klein</surname> <given-names>E</given-names>
</name>
<name>
<surname>Pross</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wigzell</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>&#x201c;Natural&#x201d; killer cells in the mouse. II. cytotoxic cells with specificity for mouse moloney leukemia cells. Characteristics of the killer</article-title>. <source>Cell Eur J Immunol</source> (<year>1975</year>) <volume>5</volume>:<page-range>117&#x2013;21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.1830050209</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Mak</surname> <given-names>TW</given-names>
</name>
<name>
<surname>Saunders</surname> <given-names>ME</given-names>
</name>
</person-group>. <article-title>14 - T cell activation</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Mak</surname> <given-names>TW</given-names>
</name>
<name>
<surname>Saunders</surname> <given-names>ME</given-names>
</name>
</person-group>, editors. <source>The immune response</source>. <publisher-loc>Burlington</publisher-loc>: <publisher-name>Academic Press</publisher-name> (<year>2006</year>). p. <fpage>373</fpage>&#x2013;<lpage>401</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/B978-012088451-3.50016-8</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vivier</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Functions of natural killer cells</article-title>. <source>Nat Immunol</source> (<year>2008</year>) <volume>9</volume>:<page-range>503&#x2013;10</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni1582</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seillet</surname> <given-names>C</given-names>
</name>
<name>
<surname>Belz</surname> <given-names>GT</given-names>
</name>
<name>
<surname>Huntington</surname> <given-names>ND</given-names>
</name>
</person-group>. <article-title>Development, homeostasis, and heterogeneity of NK cells and ILC1</article-title>. <source>Curr Top Microbiol Immunol</source> (<year>2016</year>) <volume>395</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/82_2015_474</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robertson</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Ritz</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Biology and clinical relevance of human natural killer cells</article-title>. <source>Blood</source> (<year>1990</year>) <volume>76</volume>:<fpage>2421</fpage>. doi: <pub-id pub-id-type="doi">10.1182/blood.V76.12.2421.2421</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hashemi</surname> <given-names>E</given-names>
</name>
<name>
<surname>Malarkannan</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Tissue-resident NK cells: development, maturation, and clinical relevance</article-title>. <source>Cancers (Basel)</source> (<year>2020</year>) <volume>12</volume>:<elocation-id>1553</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cancers12061553</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santoli</surname> <given-names>D</given-names>
</name>
<name>
<surname>Trinchieri</surname> <given-names>G</given-names>
</name>
<name>
<surname>Moretta</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zmijewski</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Koprowski</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Spontaneous cell-mediated cytotoxicity in humans. distribution and characterization of the effector cell</article-title>. <source>Clin Exp Immunol</source> (<year>1978</year>) <volume>33</volume>:<page-range>309&#x2013;18</page-range>.</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carrega</surname> <given-names>P</given-names>
</name>
<name>
<surname>Ferlazzo</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Natural killer cell distribution and trafficking in human tissues</article-title>. <source>Front Immunol</source> (<year>2012</year>) <volume>3</volume>:<elocation-id>347</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2012.00347</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robertson</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Soiffer</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Wolf</surname> <given-names>SF</given-names>
</name>
<name>
<surname>Manley</surname> <given-names>TJ</given-names>
</name>
<name>
<surname>Donahue</surname> <given-names>C</given-names>
</name>
<name>
<surname>Young</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF</article-title>. <source>J Exp Med</source> (<year>1992</year>) <volume>175</volume>(<issue>3</issue>):<page-range>779&#x2013;88</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.175.3.779</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campbell</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>S</given-names>
</name>
<name>
<surname>Unutmaz</surname> <given-names>D</given-names>
</name>
<name>
<surname>Soler</surname> <given-names>D</given-names>
</name>
<name>
<surname>Murphy</surname> <given-names>KE</given-names>
</name>
<name>
<surname>Hodge</surname> <given-names>MR</given-names>
</name>
<etal/>
</person-group>. <article-title>Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire</article-title>. <source>J Immunol</source> (<year>2001</year>) <volume>166</volume>:<page-range>6477&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.166.11.6477</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Juelke</surname> <given-names>K</given-names>
</name>
<name>
<surname>Killig</surname> <given-names>M</given-names>
</name>
<name>
<surname>Luetke-Eversloh</surname> <given-names>M</given-names>
</name>
<name>
<surname>Parente</surname> <given-names>E</given-names>
</name>
<name>
<surname>Gruen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Morandi</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>CD62L expression identifies a unique subset of polyfunctional CD56dimNK cells</article-title>. <source>Blood</source> (<year>2010</year>) <volume>116</volume>:<page-range>1299&#x2013;307</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2009-11-253286</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooper</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Fehniger</surname> <given-names>TA</given-names>
</name>
<name>
<surname>Turner</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>KS</given-names>
</name>
<name>
<surname>Ghaheri</surname> <given-names>BA</given-names>
</name>
<name>
<surname>Ghayur</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset</article-title>. <source>Blood</source> (<year>2001</year>) <volume>97</volume>:<page-range>3146&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood.V97.10.3146</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parolini</surname> <given-names>S</given-names>
</name>
<name>
<surname>Santoro</surname> <given-names>A</given-names>
</name>
<name>
<surname>Marcenaro</surname> <given-names>E</given-names>
</name>
<name>
<surname>Luini</surname> <given-names>W</given-names>
</name>
<name>
<surname>Massardi</surname> <given-names>L</given-names>
</name>
<name>
<surname>Facchetti</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues</article-title>. <source>Blood</source> (<year>2007</year>) <volume>109</volume>(<issue>9</issue>):<page-range>3625&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2006-08-038844</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregoire</surname> <given-names>C</given-names>
</name>
<name>
<surname>Chasson</surname> <given-names>L</given-names>
</name>
<name>
<surname>Luci</surname> <given-names>C</given-names>
</name>
<name>
<surname>Tomasello</surname> <given-names>E</given-names>
</name>
<name>
<surname>Geissmann</surname> <given-names>F</given-names>
</name>
<name>
<surname>Vivier</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>The trafficking of natural killer cells</article-title>. <source>Immunol Rev</source> (<year>2007</year>) <volume>220</volume>:<page-range>169&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1600-065X.2007.00563.x</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seillet</surname> <given-names>C</given-names>
</name>
<name>
<surname>Belz</surname> <given-names>GT</given-names>
</name>
</person-group>. <article-title>Differentiation and diversity of subsets in group 1 innate lymphoid cells</article-title>. <source>Int Immunol</source> (<year>2016</year>) <volume>28</volume>:<fpage>3</fpage>&#x2013;<lpage>11</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/intimm/dxv051</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robertson</surname> <given-names>MJ</given-names>
</name>
</person-group>. <article-title>Role of chemokines in the biology of natural killer cells</article-title>. <source>J Leukoc Biol</source> (<year>2002</year>) <volume>71</volume>:<page-range>173&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1189/JLB.71.2.173</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>H</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>C</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Expression regulation of co-inhibitory molecules on human natural killer cells in response to cytokine stimulations</article-title>. <source>Cytokine</source> (<year>2014</year>) <volume>65</volume>:<fpage>33</fpage>&#x2013;<lpage>41</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cyto.2013.09.016</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moretta</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bottino</surname> <given-names>C</given-names>
</name>
<name>
<surname>Mingari</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Biassoni</surname> <given-names>R</given-names>
</name>
<name>
<surname>Moretta</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>What is a natural killer cell</article-title>? <source>Nat Immunol</source> (<year>2002</year>) <volume>3</volume>:<fpage>6</fpage>&#x2013;<lpage>8</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni0102-6</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stanietsky</surname> <given-names>N</given-names>
</name>
<name>
<surname>Simic</surname> <given-names>H</given-names>
</name>
<name>
<surname>Arapovic</surname> <given-names>J</given-names>
</name>
<name>
<surname>Toporik</surname> <given-names>A</given-names>
</name>
<name>
<surname>Levy</surname> <given-names>O</given-names>
</name>
<name>
<surname>Novik</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity</article-title>. <source>Proc Natl Acad Sci U.S.A.</source> (<year>2009</year>) <volume>106</volume>:<page-range>17858&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0903474106</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Harden K</surname> <given-names>C</given-names>
</name>
<name>
<surname>Gonzalez</surname> <given-names>L</given-names>
</name>
<name>
<surname>Francesco</surname> <given-names>M</given-names>
</name>
<name>
<surname>Chiang</surname> <given-names>E</given-names>
</name>
<name>
<surname>Irving</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells</article-title>. <source>Nat Immunol</source> (<year>2009</year>) <volume>10</volume>:<fpage>48</fpage>&#x2013;<lpage>57</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.1674</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parham</surname> <given-names>P</given-names>
</name>
<name>
<surname>Norman</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Abi-Rached</surname> <given-names>L</given-names>
</name>
<name>
<surname>Guethlein</surname> <given-names>LA</given-names>
</name>
</person-group>. <article-title>Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules</article-title>. <source>Philos Trans R Soc B</source> (<year>2012</year>) <volume>367</volume>:<page-range>800&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1098/rstb.2011.0266</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Kadri</surname> <given-names>N</given-names>
</name>
<name>
<surname>Wagner</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Ganesan</surname> <given-names>S</given-names>
</name>
<name>
<surname>K&#xe4;rre</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wickstr&#xf6;m</surname> <given-names>S</given-names>
</name>
<name>
<surname>Johansson</surname> <given-names>MH</given-names>
</name>
<etal/>
</person-group>. <article-title>Dynamic regulation of NK cell responsiveness</article-title>. In: <source>Current topics in microbiology and immunology</source> <publisher-name>Springer</publisher-name>, <publisher-loc>Cham</publisher-loc> (<year>2015</year>) <volume>395</volume>:<fpage>95</fpage>&#x2013;<lpage>114</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/82_2015_485</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brodin</surname> <given-names>P</given-names>
</name>
<name>
<surname>K&#xe4;rre</surname> <given-names>K</given-names>
</name>
<name>
<surname>H&#xf6;glund</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>NK cell education: not an on-off switch but a tunable rheostat</article-title>. <source>Trends Immunol</source> (<year>2009</year>) <volume>30</volume>:<page-range>143&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.it.2009.01.006</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>K&#xe4;rre</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ljunggren</surname> <given-names>HG</given-names>
</name>
<name>
<surname>Piontek</surname> <given-names>G</given-names>
</name>
<name>
<surname>Kiessling</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Selective rejection of h&#x2013;2-deficient lymphoma variants suggests alternative immune defence strategy</article-title>. <source>Nature</source> (<year>1986</year>) <volume>319</volume>:<page-range>675&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/319675a0</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Maurin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>HI</given-names>
</name>
<name>
<surname>Becknell</surname> <given-names>B</given-names>
</name>
<name>
<surname>Freud</surname> <given-names>AG</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>PRDM1/Blimp-1 controls effector cytokine production in human NK cells</article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>185</volume>:<page-range>6058&#x2013;67</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1001682</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x2019;Sullivan</surname> <given-names>TE</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Lanier</surname> <given-names>LL</given-names>
</name>
</person-group>. <article-title>Natural killer cell memory</article-title>. <source>Immunity</source> (<year>2015</year>) <volume>43</volume>:<page-range>634&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2015.09.013</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vacca</surname> <given-names>P</given-names>
</name>
<name>
<surname>Mingari</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Moretta</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Natural killer cells in human pregnancy</article-title>. <source>J Reprod Immunol</source> (<year>2013</year>) <volume>97</volume>(<issue>1</issue>):<page-range>14&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jri.2012.10.008</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalkunte</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Mselle</surname> <given-names>TF</given-names>
</name>
<name>
<surname>Norris</surname> <given-names>WE</given-names>
</name>
<name>
<surname>Wira</surname> <given-names>CR</given-names>
</name>
<name>
<surname>Sentman</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Vascular endothelial growth factor c facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface</article-title>. <source>J Immunol</source> (<year>2009</year>) <volume>182</volume>:<page-range>4085&#x2013;92</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.0803769</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanna</surname> <given-names>J</given-names>
</name>
<name>
<surname>Goldman-Wohl</surname> <given-names>D</given-names>
</name>
<name>
<surname>Hamani</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Avraham</surname> <given-names>I</given-names>
</name>
<name>
<surname>Greenfield</surname> <given-names>C</given-names>
</name>
<name>
<surname>Natanson-Yaron</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Decidual NK cells regulate key developmental processes at the human fetal-maternal interface</article-title>. <source>Nat Med</source> (<year>2006</year>) <volume>12</volume>:<page-range>1065&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nm1452</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>le Bouteiller</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Human decidual NK cells: unique and tightly regulated effector functions in healthy and pathogen-infected pregnancies</article-title>. <source>Front Immunol</source> (<year>2013</year>) <volume>4</volume>:<elocation-id>404</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2013.00404</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tosello-Trampont</surname> <given-names>A</given-names>
</name>
<name>
<surname>Surette</surname> <given-names>FA</given-names>
</name>
<name>
<surname>Ewald</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Hahn</surname> <given-names>YS</given-names>
</name>
</person-group>. <article-title>Immunoregulatory role of NK cells in tissue inflammation and regeneration</article-title>. <source>Front Immunol</source> (<year>2017</year>) <volume>8</volume>:<elocation-id>301</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2017.00301</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x2019;Sullivan</surname> <given-names>TE</given-names>
</name>
<name>
<surname>Rapp</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>X</given-names>
</name>
<name>
<surname>Weizman</surname> <given-names>O-E</given-names>
</name>
<name>
<surname>Bhardwaj</surname> <given-names>P</given-names>
</name>
<name>
<surname>Adams</surname> <given-names>NM</given-names>
</name>
<etal/>
</person-group>. <article-title>Adipose-resident group 1 innate lymphoid cells promote obesity-associated insulin resistance</article-title>. <source>Immunity</source> (<year>2016</year>) <volume>45</volume>:<page-range>428&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2016.06.016</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandez</surname> <given-names>NC</given-names>
</name>
<name>
<surname>Flament</surname> <given-names>C</given-names>
</name>
<name>
<surname>Cr&#xe9;pineau</surname> <given-names>F</given-names>
</name>
<name>
<surname>Angevin</surname> <given-names>&#xc9;</given-names>
</name>
<name>
<surname>Vivier</surname> <given-names>&#xc9;</given-names>
</name>
<name>
<surname>Zitvogel</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC/NK cell cross talk</article-title>. <source>Eur Cytokine Netw</source> (<year>2002</year>) <volume>13</volume>(<issue>1</issue>):<page-range>17&#x2013;27</page-range>.</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nielsen</surname> <given-names>N</given-names>
</name>
<name>
<surname>&#xd8;dum</surname> <given-names>N</given-names>
</name>
<name>
<surname>Urs&#xf8;</surname> <given-names>B</given-names>
</name>
<name>
<surname>Lanier</surname> <given-names>LL</given-names>
</name>
<name>
<surname>Spee</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Cytotoxicity of CD56bright NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened <italic>via</italic> CD94/NKG2A</article-title>. <source>PloS One</source> (<year>2012</year>) <volume>7</volume>:<elocation-id>e31959</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0031959</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cerboni</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zingoni</surname> <given-names>A</given-names>
</name>
<name>
<surname>Cippitelli</surname> <given-names>M</given-names>
</name>
<name>
<surname>Piccoli</surname> <given-names>M</given-names>
</name>
<name>
<surname>Frati</surname> <given-names>L</given-names>
</name>
<name>
<surname>Santoni</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Antigen-activated human T lymphocytes express cell-surface NKG2D ligands <italic>via</italic> an ATM/ATR-dependent mechanism and become susceptible to autologous NK-cell lysis</article-title>. <source>Blood J Am Soc Hematol</source> (<year>2007</year>) <volume>110</volume>:<page-range>606&#x2013;15</page-range>. doi: <pub-id pub-id-type="doi">10.1182/blood-2006-10-052720</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Helige</surname> <given-names>C</given-names>
</name>
<name>
<surname>Hagendorfer</surname> <given-names>G</given-names>
</name>
<name>
<surname>Smolle</surname> <given-names>J</given-names>
</name>
<name>
<surname>Dohr</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Uterine natural killer cells in a three-dimensional tissue culture model to study trophoblast invasion</article-title>. <source>Lab Invest</source> (<year>2001</year>) <volume>81</volume>:<page-range>1153&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/labinvest.3780327</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Helige</surname> <given-names>C</given-names>
</name>
<name>
<surname>Ahammer</surname> <given-names>H</given-names>
</name>
<name>
<surname>Hammer</surname> <given-names>A</given-names>
</name>
<name>
<surname>Huppertz</surname> <given-names>B</given-names>
</name>
<name>
<surname>Frank</surname> <given-names>H-G</given-names>
</name>
<name>
<surname>Dohr</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Trophoblastic invasion <italic>in vitro</italic> and <italic>in vivo</italic>: similarities and differences</article-title>. <source>Hum Reprod</source> (<year>2008</year>) <volume>23</volume>:<page-range>2282&#x2013;91</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/humrep/den198</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abbas</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Turco</surname> <given-names>MY</given-names>
</name>
<name>
<surname>Burton</surname> <given-names>GJ</given-names>
</name>
<name>
<surname>Moffett</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Investigation of human trophoblast invasion</article-title>. <source>vitro. Hum Reprod Update</source> (<year>2020</year>) <volume>26</volume>:<page-range>501&#x2013;13</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/humupd/dmaa017</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abbas</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Oefner</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Polacheck</surname> <given-names>WJ</given-names>
</name>
<name>
<surname>Gardner</surname> <given-names>L</given-names>
</name>
<name>
<surname>Farrell</surname> <given-names>L</given-names>
</name>
<name>
<surname>Sharkey</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>A microfluidics assay to study invasion of human placental trophoblast cells</article-title>. <source>J R Soc Interface</source> (<year>2017</year>) <volume>14</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1098/rsif.2017.0131</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheridan</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Fernando</surname> <given-names>RC</given-names>
</name>
<name>
<surname>Gardner</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hollinshead</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Burton</surname> <given-names>GJ</given-names>
</name>
<name>
<surname>Moffett</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Establishment and differentiation of long-term trophoblast organoid cultures from the human placenta</article-title>. <source>Nat Protoc</source> (<year>2020</year>) <volume>15</volume>:<page-range>3441&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41596-020-0381-x</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheridan</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Fernando</surname> <given-names>RC</given-names>
</name>
<name>
<surname>Gardner</surname> <given-names>L</given-names>
</name>
<name>
<surname>Perez-Garcia</surname> <given-names>V</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>Characterization of primary models of human trophoblast</article-title>. <source>Development</source> (<year>2021</year>) <volume>148</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1242/dev.199749</pub-id>
</citation>
</ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petrova</surname> <given-names>V</given-names>
</name>
<name>
<surname>Annicchiarico-Petruzzelli</surname> <given-names>M</given-names>
</name>
<name>
<surname>Melino</surname> <given-names>G</given-names>
</name>
<name>
<surname>Amelio</surname> <given-names>I</given-names>
</name>
</person-group>. <article-title>The hypoxic tumour microenvironment</article-title>. <source>Oncogenesis</source> (<year>2018</year>) <volume>7</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41389-017-0011-9</pub-id>
</citation>
</ref>
<ref id="B76">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>JX</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>SYC</given-names>
</name>
<name>
<surname>Niu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Kang</surname> <given-names>N</given-names>
</name>
<name>
<surname>Xue</surname> <given-names>H</given-names>
</name>
<name>
<surname>Killam</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Lactic acid and an acidic tumor microenvironment suppress anticancer immunity</article-title>. <source>Int J Mol Sci</source> (<year>2020</year>) <volume>21</volume>:<fpage>1</fpage>&#x2013;<lpage>14</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms21218363</pub-id>
</citation>
</ref>
<ref id="B77">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harmon</surname> <given-names>C</given-names>
</name>
<name>
<surname>Robinson</surname> <given-names>MW</given-names>
</name>
<name>
<surname>Hand</surname> <given-names>F</given-names>
</name>
<name>
<surname>Almuaili</surname> <given-names>D</given-names>
</name>
<name>
<surname>Mentor</surname> <given-names>K</given-names>
</name>
<name>
<surname>Houlihan</surname> <given-names>DD</given-names>
</name>
<etal/>
</person-group>. <article-title>Lactate-mediated acidification of tumor microenvironment induces apoptosis of liver-resident NK cells in colorectal liver metastasis</article-title>. <source>Cancer Immunol Res</source> (<year>2019</year>) <volume>7</volume>:<page-range>335&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/2326-6066.CIR-18-0481</pub-id>
</citation>
</ref>
<ref id="B78">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brand</surname> <given-names>A</given-names>
</name>
<name>
<surname>Singer</surname> <given-names>K</given-names>
</name>
<name>
<surname>Koehl</surname> <given-names>GE</given-names>
</name>
<name>
<surname>Kolitzus</surname> <given-names>M</given-names>
</name>
<name>
<surname>Schoenhammer</surname> <given-names>G</given-names>
</name>
<name>
<surname>Thiel</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells</article-title>. <source>Cell Metab</source> (<year>2016</year>) <volume>24</volume>:<page-range>657&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cmet.2016.08.011</pub-id>
</citation>
</ref>
<ref id="B79">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ni</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Stojanovic</surname> <given-names>A</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Wincher</surname> <given-names>M</given-names>
</name>
<name>
<surname>B&#xfc;hler</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Single-cell RNA sequencing of tumor-infiltrating NK cells reveals that inhibition of transcription factor HIF-1&#x3b1; unleashes NK cell activity</article-title>. <source>Immunity</source> (<year>2020</year>) <volume>52</volume>:<fpage>1075</fpage>&#x2013;<lpage>1087.e8</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2020.05.001</pub-id>
</citation>
</ref>
<ref id="B80">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solocinski</surname> <given-names>K</given-names>
</name>
<name>
<surname>Padget</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Fabian</surname> <given-names>KP</given-names>
</name>
<name>
<surname>Wolfson</surname> <given-names>B</given-names>
</name>
<name>
<surname>Cecchi</surname> <given-names>F</given-names>
</name>
<name>
<surname>Hembrough</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Overcoming hypoxia-induced functional suppression of NK cells</article-title>. <source>J Immunother Cancer</source> (<year>2020</year>) <volume>8</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/jitc-2019-000246</pub-id>
</citation>
</ref>
<ref id="B81">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balsamo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Manzini</surname> <given-names>C</given-names>
</name>
<name>
<surname>Pietra</surname> <given-names>G</given-names>
</name>
<name>
<surname>Raggi</surname> <given-names>F</given-names>
</name>
<name>
<surname>Blengio</surname> <given-names>F</given-names>
</name>
<name>
<surname>Mingari</surname> <given-names>MC</given-names>
</name>
<etal/>
</person-group>. <article-title>Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC</article-title>. <source>Eur J Immunol</source> (<year>2013</year>) <volume>43</volume>:<page-range>2756&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.201343448</pub-id>
</citation>
</ref>
<ref id="B82">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghiringhelli</surname> <given-names>F</given-names>
</name>
<name>
<surname>M&#xe9;nard</surname> <given-names>C</given-names>
</name>
<name>
<surname>Terme</surname> <given-names>M</given-names>
</name>
<name>
<surname>Flament</surname> <given-names>C</given-names>
</name>
<name>
<surname>Taieb</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chaput</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>CD4 + CD25 + regulatory T cells inhibit natural killer cell functions in a transforming growth factor&#x2013;&#x3b2;&#x2013;dependent manner</article-title>. <source>J Exp Med</source> (<year>2005</year>) <volume>202</volume>:<page-range>1075&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20051511</pub-id>
</citation>
</ref>
<ref id="B83">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>T</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hua</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>G</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction <italic>via</italic> PGE2 and IDO</article-title>. <source>Cancer Lett</source> (<year>2012</year>) <volume>318</volume>(<issue>2</issue>):<page-range>154&#x2013;61</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.canlet.2011.12.020</pub-id>
</citation>
</ref>
<ref id="B84">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balsamo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Scordamaglia</surname> <given-names>F</given-names>
</name>
<name>
<surname>Pietra</surname> <given-names>G</given-names>
</name>
<name>
<surname>Manzini</surname> <given-names>C</given-names>
</name>
<name>
<surname>Cantoni</surname> <given-names>C</given-names>
</name>
<name>
<surname>Boitano</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity</article-title>. <source>Proc Natl Acad Sci</source> (<year>2009</year>) <volume>106</volume>(<issue>49</issue>):<page-range>20847&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0906481106</pub-id>
</citation>
</ref>
<ref id="B85">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pietra</surname> <given-names>G</given-names>
</name>
<name>
<surname>Manzini</surname> <given-names>C</given-names>
</name>
<name>
<surname>Rivara</surname> <given-names>S</given-names>
</name>
<name>
<surname>Vitale</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cantoni</surname> <given-names>C</given-names>
</name>
<name>
<surname>Petretto</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity</article-title>. <source>Cancer Res</source> (<year>2012</year>) <volume>72</volume>(<issue>6</issue>):<page-range>1407&#x2013;15</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-11-2544</pub-id>
</citation>
</ref>
<ref id="B86">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Gazzar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Groh</surname> <given-names>V</given-names>
</name>
<name>
<surname>Spies</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Immunobiology and conflicting roles of the human NKG2D lymphocyte receptor and its ligands in cancer</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>191</volume>:<page-range>1509&#x2013;15</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1301071</pub-id>
</citation>
</ref>
<ref id="B87">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarazona</surname> <given-names>R</given-names>
</name>
<name>
<surname>Borrego</surname> <given-names>F</given-names>
</name>
<name>
<surname>Vaage</surname> <given-names>JT</given-names>
</name>
<name>
<surname>Kohrt</surname> <given-names>HE</given-names>
</name>
<name>
<surname>Chester</surname> <given-names>C</given-names>
</name>
<name>
<surname>Fritsch</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Natural killer cell immunomodulation: targeting activating</article-title>. <source>inhibitory Co-stimulatory Receptor Signaling Cancer immunotherapy</source> (<year>2015</year>) <volume>6</volume>:<elocation-id>601</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2015.00601</pub-id>
</citation>
</ref>
<ref id="B88">
<label>88</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sutherland</surname> <given-names>RM</given-names>
</name>
<name>
<surname>MacDonald</surname> <given-names>HR</given-names>
</name>
<name>
<surname>Howell</surname> <given-names>RL</given-names>
</name>
</person-group>. <article-title>Multicellular spheroids: a new model target for <italic>In vitro</italic> studies of immunity to solid tumor allografts: brief communication</article-title>. <source>JNCI: J Natl Cancer Institute</source> (<year>1977</year>) <volume>58</volume>:<page-range>1849&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jnci/58.6.1849</pub-id>
</citation>
</ref>
<ref id="B89">
<label>89</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sordat</surname> <given-names>B</given-names>
</name>
<name>
<surname>MacDonald</surname> <given-names>HR</given-names>
</name>
<name>
<surname>Lees</surname> <given-names>RK</given-names>
</name>
</person-group>. <article-title>The multicellular spheroid as a model tumor allograft. III. morphological and kinetic analysis of spheroid infiltration and destruction</article-title>. <source>Transplantation</source> (<year>1980</year>) <volume>29</volume>:<page-range>103&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/00007890-198002000-00004</pub-id>
</citation>
</ref>
<ref id="B90">
<label>90</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacDonald</surname> <given-names>HR</given-names>
</name>
<name>
<surname>Howell</surname> <given-names>RL</given-names>
</name>
</person-group>. <article-title>The multicellular spheroid as a model tumor allograft. i. quantitative assessment of spheroid destruction in alloimmune mice</article-title>. <source>Transplantation</source> (<year>1978</year>) <volume>25</volume>:<page-range>136&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/00007890-197803000-00008</pub-id>
</citation>
</ref>
<ref id="B91">
<label>91</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacDonald</surname> <given-names>HR</given-names>
</name>
<name>
<surname>Howell</surname> <given-names>RL</given-names>
</name>
<name>
<surname>McFarlane</surname> <given-names>DL</given-names>
</name>
</person-group>. <article-title>The multicellular spheroid as a model tumor allograft. II. characterization of spheroid-infiltrating cytotoxic cells</article-title>. <source>Transplantation</source> (<year>1978</year>) <volume>25</volume>:<page-range>141&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/00007890-197803000-00009</pub-id>
</citation>
</ref>
<ref id="B92">
<label>92</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ayuso</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Truttschel</surname> <given-names>R</given-names>
</name>
<name>
<surname>Gong</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Humayun</surname> <given-names>M</given-names>
</name>
<name>
<surname>Virumbrales-Munoz</surname> <given-names>M</given-names>
</name>
<name>
<surname>Vitek</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Evaluating natural killer cell cytotoxicity against solid tumors using a microfluidic model</article-title>. <source>Oncoimmunology</source> (<year>2019</year>) <volume>8</volume>:<fpage>1</fpage>&#x2013;<lpage>11</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/2162402X.2018.1553477</pub-id>
</citation>
</ref>
<ref id="B93">
<label>93</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marrella</surname> <given-names>A</given-names>
</name>
<name>
<surname>Buratti</surname> <given-names>P</given-names>
</name>
<name>
<surname>Markus</surname> <given-names>J</given-names>
</name>
<name>
<surname>Firpo</surname> <given-names>G</given-names>
</name>
<name>
<surname>Pesenti</surname> <given-names>M</given-names>
</name>
<name>
<surname>Landry</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>
<italic>In vitro</italic> demonstration of intestinal absorption mechanisms of different sugars using 3D organotypic tissues in a fluidic device</article-title>. <source>ALTEX</source> (<year>2020</year>) <volume>37</volume>:<page-range>255&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.14573/altex.1908311</pub-id>
</citation>
</ref>
<ref id="B94">
<label>94</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marrella</surname> <given-names>A</given-names>
</name>
<name>
<surname>Varani</surname> <given-names>G</given-names>
</name>
<name>
<surname>Aiello</surname> <given-names>M</given-names>
</name>
<name>
<surname>Vaccari</surname> <given-names>I</given-names>
</name>
<name>
<surname>Vitale</surname> <given-names>C</given-names>
</name>
<name>
<surname>Mojzisek</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>3D fluid-dynamic ovarian cancer model resembling systemic drug administration for efficacy assay</article-title>. <source>ALTEX</source> (<year>2021</year>) <volume>38</volume>:<fpage>82</fpage>&#x2013;<lpage>94</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.14573/altex.2003131</pub-id>
</citation>
</ref>
<ref id="B95">
<label>95</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marzagalli</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pelizzoni</surname> <given-names>G</given-names>
</name>
<name>
<surname>Fedi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Vitale</surname> <given-names>C</given-names>
</name>
<name>
<surname>Fontana</surname> <given-names>F</given-names>
</name>
<name>
<surname>Bruno</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>A multi-organ-on-chip to recapitulate the infiltration and the cytotoxic activity of circulating NK cells in 3D matrix-based tumor model</article-title>. <source>Front Bioeng Biotechnol</source> (<year>2022</year>) <volume>10</volume>:<elocation-id>945149</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fbioe.2022.945149</pub-id>
</citation>
</ref>
<ref id="B96">
<label>96</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mclimans</surname> <given-names>WF</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>EV</given-names>
</name>
<name>
<surname>Glover</surname> <given-names>FL</given-names>
</name>
<name>
<surname>Rake</surname> <given-names>GW</given-names>
</name>
</person-group>. <article-title>The submerged culture of mammalian cells; the spinner culture</article-title>. <source>J Immunol</source> (<year>1957</year>) <volume>79</volume>:<page-range>428&#x2013;33</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.79.5.428</pub-id>
</citation>
</ref>
<ref id="B97">
<label>97</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lord</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Burkhardt</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Assessment of <italic>in situ</italic> host immunity to syngeneic tumors utilizing the multicellular spheroid model</article-title>. <source>Cell Immunol</source> (<year>1984</year>) <volume>85</volume>:<page-range>340&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0008-8749(84)90248-x</pub-id>
</citation>
</ref>
<ref id="B98">
<label>98</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwasaki</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kikuchi</surname> <given-names>H</given-names>
</name>
<name>
<surname>Miyatake</surname> <given-names>SI</given-names>
</name>
<name>
<surname>Aoki</surname> <given-names>T</given-names>
</name>
<name>
<surname>Yamasaki</surname> <given-names>T</given-names>
</name>
<name>
<surname>Oda</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Infiltrative and cytolytic activities of lymphokine-activated killer cells against a human glioma spheroid model</article-title>. <source>Cancer Res</source> (<year>1990</year>) <volume>50</volume>:<page-range>2429&#x2013;36</page-range>.</citation>
</ref>
<ref id="B99">
<label>99</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sutherland</surname> <given-names>RM</given-names>
</name>
<name>
<surname>McCredie</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Inch</surname> <given-names>WR</given-names>
</name>
</person-group>. <article-title>Growth of multicell spheroids in tissue culture as a model of nodular carcinomas</article-title>. <source>J Natl Cancer Inst</source> (<year>1971</year>) <volume>46</volume>:<page-range>113&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jnci/46.1.113</pub-id>
</citation>
</ref>
<ref id="B100">
<label>100</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sutherland</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Durand</surname> <given-names>RE</given-names>
</name>
</person-group>. <article-title>Growth and cellular characteristics of multicell spheroids</article-title>. <source>Recent Results Cancer Res</source> (<year>1984</year>) <volume>95</volume>:<fpage>24</fpage>&#x2013;<lpage>49</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-3-642-82340-4_2</pub-id>
</citation>
</ref>
<ref id="B101">
<label>101</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname> <given-names>W</given-names>
</name>
<name>
<surname>Kuang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>X</given-names>
</name>
<name>
<surname>Simpson</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Proteomic comparison of 3D and 2D glioma models reveals increased HLA-e expression in 3D models is associated with resistance to NK cell-mediated cytotoxicity</article-title>. <source>J Proteome Res</source> (<year>2014</year>) <volume>13</volume>:<page-range>2272&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/pr500064m</pub-id>
</citation>
</ref>
<ref id="B102">
<label>102</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelm</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Fussenegger</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Microscale tissue engineering using gravity-enforced cell assembly</article-title>. <source>Trends Biotechnol</source> (<year>2004</year>) <volume>22</volume>:<fpage>195</fpage>&#x2013;<lpage>202</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tibtech.2004.02.002</pub-id>
</citation>
</ref>
<ref id="B103">
<label>103</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carlsson</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yuhas</surname> <given-names>JM</given-names>
</name>
</person-group>. <article-title>Liquid-overlay culture of cellular spheroids</article-title>. <source>Recent Results Cancer Res</source> (<year>1984</year>) <volume>95</volume>:<fpage>1</fpage>&#x2013;<lpage>23</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-3-642-82340-4_1</pub-id>
</citation>
</ref>
<ref id="B104">
<label>104</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuhas</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Li</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Martinez</surname> <given-names>AO</given-names>
</name>
<name>
<surname>Ladman</surname> <given-names>AJ</given-names>
</name>
</person-group>. <article-title>A simplified method for production and growth of multicellular tumor spheroids</article-title>. <source>Cancer Res</source> (<year>1977</year>) <volume>37</volume>:<page-range>3639&#x2013;43</page-range>.</citation>
</ref>
<ref id="B105">
<label>105</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia de Palazzo</surname> <given-names>I</given-names>
</name>
<name>
<surname>Holmes</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gercel-Taylor</surname> <given-names>C</given-names>
</name>
<name>
<surname>Weiner</surname> <given-names>LM</given-names>
</name>
</person-group>. <article-title>Antitumor effects of a bispecific antibody targeting CA19-9 antigen and CD16</article-title>. <source>Cancer Res</source> (<year>1992</year>) <volume>52</volume>:<page-range>5713&#x2013;9</page-range>.</citation>
</ref>
<ref id="B106">
<label>106</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giannattasio</surname> <given-names>A</given-names>
</name>
<name>
<surname>Weil</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kloess</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ansari</surname> <given-names>N</given-names>
</name>
<name>
<surname>Stelzer</surname> <given-names>EHK</given-names>
</name>
<name>
<surname>Cerwenka</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Cytotoxicity and infiltration of human NK cells in <italic>in vivo</italic>-like tumor spheroids</article-title>. <source>BMC Cancer</source> (<year>2015</year>) <volume>15</volume>:<fpage>351</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12885-015-1321-y</pub-id>
</citation>
</ref>
<ref id="B107">
<label>107</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ivascu</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kubbies</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis</article-title>. <source>J Biomol Screen</source> (<year>2006</year>) <volume>11</volume>:<page-range>922&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/1087057106292763</pub-id>
</citation>
</ref>
<ref id="B108">
<label>108</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lawrenson</surname> <given-names>K</given-names>
</name>
<name>
<surname>Grun</surname> <given-names>B</given-names>
</name>
<name>
<surname>Gayther</surname> <given-names>SA</given-names>
</name>
</person-group>. <article-title>Heterotypic three-dimensional in vitro modeling of stromal-epithelial interactions during ovarian cancer initiation and progression</article-title>. <source>J Vis Exp</source> (<year>2012</year>):<elocation-id>e4206</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3791/4206</pub-id>
</citation>
</ref>
<ref id="B109">
<label>109</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>del Bano</surname> <given-names>J</given-names>
</name>
<name>
<surname>Flor&#xe8;s-Flor&#xe8;s</surname> <given-names>R</given-names>
</name>
<name>
<surname>Josselin</surname> <given-names>E</given-names>
</name>
<name>
<surname>Goubard</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ganier</surname> <given-names>L</given-names>
</name>
<name>
<surname>Castellano</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>A bispecific antibody-based approach for targeting mesothelin in triple negative breast cancer</article-title>. <source>Front Immunol</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>1593</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.01593</pub-id>
</citation>
</ref>
<ref id="B110">
<label>110</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murphy</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>T</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>X</given-names>
</name>
<name>
<surname>Adjei</surname> <given-names>IM</given-names>
</name>
</person-group>. <article-title>Reversing hypoxia with PLGA-encapsulated manganese dioxide nanoparticles improves natural killer cell response to tumor spheroids</article-title>. <source>Mol Pharm</source> (<year>2021</year>) <volume>18</volume>:<page-range>2935&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.1c00085</pub-id>
</citation>
</ref>
<ref id="B111">
<label>111</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>J&#xe4;&#xe4;skel&#xe4;inen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lehtonen</surname> <given-names>E</given-names>
</name>
<name>
<surname>Heikkil&#xe4;</surname> <given-names>P</given-names>
</name>
<name>
<surname>Kalliom&#xe4;ki</surname> <given-names>P</given-names>
</name>
<name>
<surname>Timonen</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Damage to multicellular human h-2 glioma spheroids incubated with LAK cells: an ultrastructural study</article-title>. <source>J Natl Cancer Inst</source> (<year>1990</year>) <volume>82</volume>:<fpage>497</fpage>&#x2013;<lpage>501</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jnci/82.6.497</pub-id>
</citation>
</ref>
<ref id="B112">
<label>112</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>J&#xe4;&#xe4;skel&#xe4;inen</surname> <given-names>J</given-names>
</name>
<name>
<surname>M&#xe4;enp&#xe4;&#xe4;</surname> <given-names>A</given-names>
</name>
<name>
<surname>Patarroyo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gahmberg</surname> <given-names>CG</given-names>
</name>
<name>
<surname>Somersalo</surname> <given-names>K</given-names>
</name>
<name>
<surname>Tarkkanen</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Migration of recombinant IL-2-activated T and natural killer cells in the intercellular space of human h-2 glioma spheroids <italic>in vitro.</italic> a study on adhesion molecules involved</article-title>. <source>J Immunol</source> (<year>1992</year>) <volume>149</volume>:<page-range>260&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.149.1.260</pub-id>
</citation>
</ref>
<ref id="B113">
<label>113</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nederman</surname> <given-names>T</given-names>
</name>
<name>
<surname>Norling</surname> <given-names>B</given-names>
</name>
<name>
<surname>Glimelius</surname> <given-names>B</given-names>
</name>
<name>
<surname>Carlsson</surname> <given-names>J</given-names>
</name>
<name>
<surname>Brunk</surname> <given-names>U</given-names>
</name>
</person-group>. <article-title>Demonstration of an extracellular matrix in multicellular tumor spheroids</article-title>. <source>Cancer Res</source> (<year>1984</year>) <volume>44</volume>:<page-range>3090&#x2013;7</page-range>.</citation>
</ref>
<ref id="B114">
<label>114</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>YE</given-names>
</name>
<name>
<surname>Yuk</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>M</given-names>
</name>
<name>
<surname>Han</surname> <given-names>K-C</given-names>
</name>
<name>
<surname>Jun</surname> <given-names>E</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>TS</given-names>
</name>
<etal/>
</person-group>. <article-title>Facile discovery of a therapeutic agent for NK-mediated synergistic antitumor effects using a patient-derived 3D platform</article-title>. <source>Biomater Sci</source> (<year>2022</year>) <volume>10</volume>:<page-range>678&#x2013;91</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/d1bm01699g</pub-id>
</citation>
</ref>
<ref id="B115">
<label>115</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>J&#xe4;&#xe4;skel&#xe4;inen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kalliom&#xe4;ki</surname> <given-names>P</given-names>
</name>
<name>
<surname>Paetau</surname> <given-names>A</given-names>
</name>
<name>
<surname>Timonen</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Effect of LAK cells against three-dimensional tumor tissue. <italic>In vitro</italic> study using multi-cellular human glioma spheroids as targets</article-title>. <source>J Immunol</source> (<year>1989</year>) <volume>142</volume>:<page-range>1036&#x2013;45</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.142.3.1036</pub-id>
</citation>
</ref>
<ref id="B116">
<label>116</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaaijk</surname> <given-names>P</given-names>
</name>
<name>
<surname>Troost</surname> <given-names>D</given-names>
</name>
<name>
<surname>Dast</surname> <given-names>PK</given-names>
</name>
<name>
<surname>van den Berg</surname> <given-names>F</given-names>
</name>
<name>
<surname>Leenstra</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bosch</surname> <given-names>DA</given-names>
</name>
</person-group>. <article-title>Cytolytic effects of autologous lymphokine-activated killer cells on organotypic multicellular spheroids of gliomas <italic>in vitro</italic>
</article-title>. <source>Neuropathol Appl Neurobiol</source> (<year>1995</year>) <volume>21</volume>:<page-range>392&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2990.1995.tb01076.x</pub-id>
</citation>
</ref>
<ref id="B117">
<label>117</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sargenti</surname> <given-names>A</given-names>
</name>
<name>
<surname>Musmeci</surname> <given-names>F</given-names>
</name>
<name>
<surname>Bacchi</surname> <given-names>F</given-names>
</name>
<name>
<surname>Delprete</surname> <given-names>C</given-names>
</name>
<name>
<surname>Cristaldi</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Cannas</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Physical characterization of colorectal cancer spheroids and evaluation of NK cell infiltration through a flow-based analysis</article-title>. <source>Front Immunol</source> (<year>2020</year>) <volume>11</volume>:<elocation-id>564887</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.564887</pub-id>
</citation>
</ref>
<ref id="B118">
<label>118</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weil</surname> <given-names>S</given-names>
</name>
<name>
<surname>Memmer</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lechner</surname> <given-names>A</given-names>
</name>
<name>
<surname>Huppert</surname> <given-names>V</given-names>
</name>
<name>
<surname>Giannattasio</surname> <given-names>A</given-names>
</name>
<name>
<surname>Becker</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Natural killer group 2D ligand depletion reconstitutes natural killer cell immunosurveillance of head and neck squamous cell carcinoma</article-title>. <source>Front Immunol</source> (<year>2017</year>) <volume>8</volume>:<elocation-id>387</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2017.00387</pub-id>
</citation>
</ref>
<ref id="B119">
<label>119</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Courau</surname> <given-names>T</given-names>
</name>
<name>
<surname>Bonnereau</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chicoteau</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bottois</surname> <given-names>H</given-names>
</name>
<name>
<surname>Remark</surname> <given-names>R</given-names>
</name>
<name>
<surname>Assante Miranda</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment</article-title>. <source>J Immunother Cancer</source> (<year>2019</year>) <volume>7</volume>:<fpage>74</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s40425-019-0553-9</pub-id>
</citation>
</ref>
<ref id="B120">
<label>120</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Susek</surname> <given-names>KH</given-names>
</name>
<name>
<surname>Schwietzer</surname> <given-names>YA</given-names>
</name>
<name>
<surname>Karvouni</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gilljam</surname> <given-names>M</given-names>
</name>
<name>
<surname>Keszei</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hussain</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Generation of NK cells with chimeric-switch receptors to overcome PD1-mediated inhibition in cancer immunotherapy</article-title>. <source>Cancer Immunol Immunother</source> (<year>2022</year>) <volume>72</volume>:<page-range>1153&#x2013;67</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00262-022-03317-y</pub-id>
</citation>
</ref>
<ref id="B121">
<label>121</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonz&#xe1;lez-Llorente</surname> <given-names>L</given-names>
</name>
<name>
<surname>Santacatterina</surname> <given-names>F</given-names>
</name>
<name>
<surname>Garc&#xed;a-Aguilar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Nuevo-Tapioles</surname> <given-names>C</given-names>
</name>
<name>
<surname>Gonz&#xe1;lez-Garc&#xed;a</surname> <given-names>S</given-names>
</name>
<name>
<surname>Tirpakova</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Overexpression of mitochondrial IF1 prevents metastatic disease of colorectal cancer by enhancing anoikis and tumor infiltration of NK cells</article-title>. <source>Cancers (Basel)</source> (<year>2019</year>) <volume>12</volume>:<elocation-id>22</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cancers12010022</pub-id>
</citation>
</ref>
<ref id="B122">
<label>122</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffmann</surname> <given-names>TK</given-names>
</name>
<name>
<surname>Schirlau</surname> <given-names>K</given-names>
</name>
<name>
<surname>Sonkoly</surname> <given-names>E</given-names>
</name>
<name>
<surname>Brandau</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Pivarcsi</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>A novel mechanism for anti-EGFR antibody action involves chemokine-mediated leukocyte infiltration</article-title>. <source>Int J Cancer</source> (<year>2009</year>) <volume>124</volume>:<page-range>2589&#x2013;96</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ijc.24269</pub-id>
</citation>
</ref>
<ref id="B123">
<label>123</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoogstad-van Evert</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Cany</surname> <given-names>J</given-names>
</name>
<name>
<surname>van den Brand</surname> <given-names>D</given-names>
</name>
<name>
<surname>Oudenampsen</surname> <given-names>M</given-names>
</name>
<name>
<surname>Brock</surname> <given-names>R</given-names>
</name>
<name>
<surname>Torensma</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Umbilical cord blood CD34+ progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD/SCID/IL2Rgnull mice</article-title>. <source>Oncoimmunology</source> (<year>2017</year>) <volume>6</volume>:<elocation-id>e1320630</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/2162402X.2017.1320630</pub-id>
</citation>
</ref>
<ref id="B124">
<label>124</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maas</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Hoogstad-van Evert</surname> <given-names>JS</given-names>
</name>
<name>
<surname>van der Meer</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Mekers</surname> <given-names>V</given-names>
</name>
<name>
<surname>Rezaeifard</surname> <given-names>S</given-names>
</name>
<name>
<surname>Korman</surname> <given-names>AJ</given-names>
</name>
<etal/>
</person-group>. <article-title>TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer</article-title>. <source>Oncoimmunology</source> (<year>2020</year>) <volume>9</volume>:<elocation-id>1843247</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/2162402X.2020.1843247</pub-id>
</citation>
</ref>
<ref id="B125">
<label>125</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Decaup</surname> <given-names>E</given-names>
</name>
<name>
<surname>Rossi</surname> <given-names>C</given-names>
</name>
<name>
<surname>Gravelle</surname> <given-names>P</given-names>
</name>
<name>
<surname>Laurent</surname> <given-names>C</given-names>
</name>
<name>
<surname>Bordenave</surname> <given-names>J</given-names>
</name>
<name>
<surname>Tosolini</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>A tridimensional model for NK cell-mediated ADCC of follicular lymphoma</article-title>. <source>Front Immunol</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>1943</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.01943</pub-id>
</citation>
</ref>
<ref id="B126">
<label>126</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guti</surname> <given-names>E</given-names>
</name>
<name>
<surname>Regdon</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Sturniolo</surname> <given-names>I</given-names>
</name>
<name>
<surname>Kiss</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kov&#xe1;cs</surname> <given-names>K</given-names>
</name>
<name>
<surname>Dem&#xe9;ny</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC</article-title>. <source>Cancer Immunol Immunother</source> (<year>2022</year>) <volume>71</volume>:<page-range>2151&#x2013;68</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00262-022-03146-z</pub-id>
</citation>
</ref>
<ref id="B127">
<label>127</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rademacher</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Cruz</surname> <given-names>A</given-names>
</name>
<name>
<surname>Faber</surname> <given-names>M</given-names>
</name>
<name>
<surname>Oldham</surname> <given-names>RAA</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Medin</surname> <given-names>JA</given-names>
</name>
<etal/>
</person-group>. <article-title>Sarcoma IL-12 overexpression facilitates NK cell immunomodulation</article-title>. <source>Sci Rep</source> (<year>2021</year>) <volume>11</volume>:<fpage>8321</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-021-87700-2</pub-id>
</citation>
</ref>
<ref id="B128">
<label>128</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aarsund</surname> <given-names>M</given-names>
</name>
<name>
<surname>Segers</surname> <given-names>FM</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Inngjerdingen</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Comparison of characteristics and tumor targeting properties of extracellular vesicles derived from primary NK cells or NK-cell lines stimulated with IL-15 or IL-12/15/18</article-title>. <source>Cancer Immunol Immunother</source> (<year>2022</year>) <volume>71</volume>:<page-range>2227&#x2013;38</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00262-022-03161-0</pub-id>
</citation>
</ref>
<ref id="B129">
<label>129</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ochalek</surname> <given-names>T</given-names>
</name>
<name>
<surname>von Kleist</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Study of the susceptibility of human colorectal tumor explants to LAK-cell lysis: comparison of various cytotoxicity tests</article-title>. <source>J Clin Lab Anal</source> (<year>1993</year>) <volume>7</volume>:<page-range>155&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jcla.1860070305</pub-id>
</citation>
</ref>
<ref id="B130">
<label>130</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ochalek</surname> <given-names>T</given-names>
</name>
<name>
<surname>von Kleist</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Study of the resistance of tumor-cell spheroids to penetration and lysis by activated effector cells</article-title>. <source>Int J Cancer</source> (<year>1994</year>) <volume>57</volume>:<fpage>399</fpage>&#x2013;<lpage>405</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ijc.2910570318</pub-id>
</citation>
</ref>
<ref id="B131">
<label>131</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knelson</surname> <given-names>EH</given-names>
</name>
<name>
<surname>v.</surname> <given-names>IE</given-names>
</name>
<name>
<surname>Tarannum</surname> <given-names>M</given-names>
</name>
<name>
<surname>Campisi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lizotte</surname> <given-names>PH</given-names>
</name>
<name>
<surname>Booker</surname> <given-names>MA</given-names>
</name>
<etal/>
</person-group>. <article-title>Activation of tumor-cell STING primes NK-cell therapy</article-title>. <source>Cancer Immunol Res</source> (<year>2022</year>) <volume>10</volume>:<page-range>947&#x2013;61</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/2326-6066.CIR-22-0017</pub-id>
</citation>
</ref>
<ref id="B132">
<label>132</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Goodman</surname> <given-names>SR</given-names>
</name>
</person-group>. <article-title>Cell adhesion and the extracellular matrix</article-title>. In: <source>Goodman&#x2019;s medical cell biology</source>. <publisher-name>Elsevier</publisher-name> (<year>2021</year>). p. <page-range>203&#x2013;47</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/B978-0-12-817927-7.00007-7</pub-id>
</citation>
</ref>
<ref id="B133">
<label>133</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelm</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Timmins</surname> <given-names>NE</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Fussenegger</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nielsen</surname> <given-names>LK</given-names>
</name>
</person-group>. <article-title>Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types</article-title>. <source>Biotechnol Bioeng</source> (<year>2003</year>) <volume>83</volume>:<page-range>173&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/bit.10655</pub-id>
</citation>
</ref>
<ref id="B134">
<label>134</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keller</surname> <given-names>GM</given-names>
</name>
</person-group>. <article-title>
<italic>In vitro</italic> differentiation of embryonic stem cells</article-title>. <source>Curr Opin Cell Biol</source> (<year>1995</year>) <volume>7</volume>:<page-range>862&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0955-0674(95)80071-9</pub-id>
</citation>
</ref>
<ref id="B135">
<label>135</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lanuza</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Vigueras</surname> <given-names>A</given-names>
</name>
<name>
<surname>Olivan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Prats</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Costas</surname> <given-names>S</given-names>
</name>
<name>
<surname>Llamazares</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Activated human primary NK cells efficiently kill colorectal cancer cells in 3D spheroid cultures irrespectively of the level of PD-L1 expression</article-title>. <source>Oncoimmunology</source> (<year>2018</year>) <volume>7</volume>:<elocation-id>e1395123</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/2162402X.2017.1395123</pub-id>
</citation>
</ref>
<ref id="B136">
<label>136</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tung</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hsiao</surname> <given-names>AY</given-names>
</name>
<name>
<surname>Allen</surname> <given-names>SG</given-names>
</name>
<name>
<surname>Torisawa</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ho</surname> <given-names>M</given-names>
</name>
<name>
<surname>Takayama</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array</article-title>. <source>Analyst</source> (<year>2011</year>) <volume>136</volume>:<page-range>473&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/c0an00609b</pub-id>
</citation>
</ref>
<ref id="B137">
<label>137</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drewitz</surname> <given-names>M</given-names>
</name>
<name>
<surname>Helbling</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fried</surname> <given-names>N</given-names>
</name>
<name>
<surname>Bieri</surname> <given-names>M</given-names>
</name>
<name>
<surname>Moritz</surname> <given-names>W</given-names>
</name>
<name>
<surname>Lichtenberg</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues</article-title>. <source>Biotechnol J</source> (<year>2011</year>) <volume>6</volume>:<page-range>1488&#x2013;96</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/biot.201100290</pub-id>
</citation>
</ref>
<ref id="B138">
<label>138</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Messner</surname> <given-names>S</given-names>
</name>
<name>
<surname>Agarkova</surname> <given-names>I</given-names>
</name>
<name>
<surname>Moritz</surname> <given-names>W</given-names>
</name>
<name>
<surname>Kelm</surname> <given-names>JM</given-names>
</name>
</person-group>. <article-title>Multi-cell type human liver microtissues for hepatotoxicity testing</article-title>. <source>Arch Toxicol</source> (<year>2013</year>) <volume>87</volume>:<page-range>209&#x2013;13</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00204-012-0968-2</pub-id>
</citation>
</ref>
<ref id="B139">
<label>139</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wardwell-Swanson</surname> <given-names>J</given-names>
</name>
<name>
<surname>Suzuki</surname> <given-names>M</given-names>
</name>
<name>
<surname>Dowell</surname> <given-names>KG</given-names>
</name>
<name>
<surname>Bieri</surname> <given-names>M</given-names>
</name>
<name>
<surname>Thoma</surname> <given-names>EC</given-names>
</name>
<name>
<surname>Agarkova</surname> <given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>A framework for optimizing high-content imaging of 3D models for drug discovery</article-title>. <source>SLAS Discovery</source> (<year>2020</year>) <volume>25</volume>:<page-range>709&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/2472555220929291</pub-id>
</citation>
</ref>
<ref id="B140">
<label>140</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Title</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Karsai</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mir-Coll</surname> <given-names>J</given-names>
</name>
<name>
<surname>Grining</surname> <given-names>&#xd6;Y</given-names>
</name>
<name>
<surname>Rufer</surname> <given-names>C</given-names>
</name>
<name>
<surname>Sonntag</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Evaluation of the effects of harmine on &#x3b2;-cell function and proliferation in standardized human islets using 3D high-content confocal imaging and automated analysis</article-title>. <source>Front Endocrinol (Lausanne)</source> (<year>2022</year>) <volume>13</volume>:<elocation-id>854094</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2022.854094</pub-id>
</citation>
</ref>
<ref id="B141">
<label>141</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Badea</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Balas</surname> <given-names>M</given-names>
</name>
<name>
<surname>Dinischiotu</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Biological properties and development of hypoxia in a breast cancer 3D model generated by hanging drop technique</article-title>. <source>Cell Biochem Biophys</source> (<year>2022</year>) <volume>80</volume>:<fpage>63</fpage>&#x2013;<lpage>73</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12013-021-00982-1</pub-id>
</citation>
</ref>
<ref id="B142">
<label>142</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herter</surname> <given-names>S</given-names>
</name>
<name>
<surname>Morra</surname> <given-names>L</given-names>
</name>
<name>
<surname>Schlenker</surname> <given-names>R</given-names>
</name>
<name>
<surname>Sulcova</surname> <given-names>J</given-names>
</name>
<name>
<surname>Fahrni</surname> <given-names>L</given-names>
</name>
<name>
<surname>Waldhauer</surname> <given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agents</article-title>. <source>Cancer Immunol Immunother</source> (<year>2017</year>) <volume>66</volume>:<page-range>129&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00262-016-1927-1</pub-id>
</citation>
</ref>
<ref id="B143">
<label>143</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>D</given-names>
</name>
<name>
<surname>Son</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hwang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ko</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Doh</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>High-throughput microfluidic 3D cytotoxicity assay for cancer immunotherapy (CACI-ImpacT platform)</article-title>. <source>Front Immunol</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>1133</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.01133</pub-id>
</citation>
</ref>
<ref id="B144">
<label>144</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schnalzger</surname> <given-names>TE</given-names>
</name>
<name>
<surname>de Groot</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Mosa</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Michels</surname> <given-names>BE</given-names>
</name>
<name>
<surname>R&#xf6;der</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids</article-title>. <source>EMBO J</source> (<year>2019</year>) <volume>38</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.15252/embj.2018100928</pub-id>
</citation>
</ref>
<ref id="B145">
<label>145</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tibbitt</surname> <given-names>MW</given-names>
</name>
<name>
<surname>Anseth</surname> <given-names>KS</given-names>
</name>
</person-group>. <article-title>Hydrogels as extracellular matrix mimics for 3D cell culture</article-title>. <source>Biotechnol Bioeng</source> (<year>2009</year>) <volume>103</volume>:<page-range>655&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/bit.22361</pub-id>
</citation>
</ref>
<ref id="B146">
<label>146</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gopal</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kwon</surname> <given-names>S-J</given-names>
</name>
<name>
<surname>Ku</surname> <given-names>B</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>DW</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>J</given-names>
</name>
<name>
<surname>Dordick</surname> <given-names>JS</given-names>
</name>
</person-group>. <article-title>3D tumor spheroid microarray for high-throughput, high-content natural killer cell-mediated cytotoxicity</article-title>. <source>Commun Biol</source> (<year>2021</year>) <volume>4</volume>:<fpage>893</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s42003-021-02417-2</pub-id>
</citation>
</ref>
<ref id="B147">
<label>147</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishikura</surname> <given-names>H</given-names>
</name>
<name>
<surname>Takahashi</surname> <given-names>C</given-names>
</name>
<name>
<surname>Kanagawa</surname> <given-names>K</given-names>
</name>
<name>
<surname>Togashi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Koyanagi</surname> <given-names>T</given-names>
</name>
<name>
<surname>Yoshiki</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Susceptibility of renal tubular cells to lymphokine-activated killer (LAK) cells: application of culture system using a collagen gel matrix</article-title>. <source>Virchows Arch B Cell Pathol Incl Mol Pathol</source> (<year>1993</year>) <volume>63</volume>:<page-range>115&#x2013;21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/BF02899250</pub-id>
</citation>
</ref>
<ref id="B148">
<label>148</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ayuso</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Virumbrales-Mu&#xf1;oz</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lacueva</surname> <given-names>A</given-names>
</name>
<name>
<surname>Lanuza</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Checa-Chavarria</surname> <given-names>E</given-names>
</name>
<name>
<surname>Botella</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Development and characterization of a microfluidic model of the tumour microenvironment</article-title>. <source>Sci Rep</source> (<year>2016</year>) <volume>6</volume>:<elocation-id>36086</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/srep36086</pub-id>
</citation>
</ref>
<ref id="B149">
<label>149</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ayuso</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Rehman</surname> <given-names>S</given-names>
</name>
<name>
<surname>Virumbrales-Munoz</surname> <given-names>M</given-names>
</name>
<name>
<surname>McMinn</surname> <given-names>PH</given-names>
</name>
<name>
<surname>Geiger</surname> <given-names>P</given-names>
</name>
<name>
<surname>Fitzgerald</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Microfluidic tumor-on-a-chip model to evaluate the role of tumor environmental stress on NK cell exhaustion</article-title>. <source>Sci Adv</source> (<year>2021</year>) <volume>7</volume>:<fpage>1</fpage>&#x2013;<lpage>14</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/sciadv.abc2331</pub-id>
</citation>
</ref>
<ref id="B150">
<label>150</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marrella</surname> <given-names>A</given-names>
</name>
<name>
<surname>Dondero</surname> <given-names>A</given-names>
</name>
<name>
<surname>Aiello</surname> <given-names>M</given-names>
</name>
<name>
<surname>Casu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Olive</surname> <given-names>D</given-names>
</name>
<name>
<surname>Regis</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Cell-laden hydrogel as a clinical-relevant 3D model for analyzing neuroblastoma growth, immunophenotype, and susceptibility to therapies</article-title>. <source>Front Immunol</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>1876</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.01876</pub-id>
</citation>
</ref>
<ref id="B151">
<label>151</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Temples</surname> <given-names>MN</given-names>
</name>
<name>
<surname>Adjei</surname> <given-names>IM</given-names>
</name>
<name>
<surname>Nimocks</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Djeu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Engineered three-dimensional tumor models to study natural killer cell suppression</article-title>. <source>ACS Biomater Sci Eng</source> (<year>2020</year>) <volume>6</volume>:<page-range>4179&#x2013;99</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/acsbiomaterials.0c00259</pub-id>
</citation>
</ref>
<ref id="B152">
<label>152</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname> <given-names>OTP</given-names>
</name>
<name>
<surname>Misun</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Lohasz</surname> <given-names>C</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Schroeder</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>An immunocompetent microphysiological system to simultaneously investigate effects of anti-tumor natural killer cells on tumor and cardiac microtissues</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>781337</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.781337</pub-id>
</citation>
</ref>
<ref id="B153">
<label>153</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lohasz</surname> <given-names>C</given-names>
</name>
<name>
<surname>Rousset</surname> <given-names>N</given-names>
</name>
<name>
<surname>Renggli</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hierlemann</surname> <given-names>A</given-names>
</name>
<name>
<surname>Frey</surname> <given-names>O</given-names>
</name>
</person-group>. <article-title>Scalable microfluidic platform for flexible configuration of and experiments with microtissue multiorgan models</article-title>. <source>SLAS Technol</source> (<year>2019</year>) <volume>24</volume>:<fpage>79</fpage>&#x2013;<lpage>95</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/2472630318802582</pub-id>
</citation>
</ref>
<ref id="B154">
<label>154</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christakou</surname> <given-names>AE</given-names>
</name>
<name>
<surname>Ohlin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Onfelt</surname> <given-names>B</given-names>
</name>
<name>
<surname>Wiklund</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Ultrasonic three-dimensional on-chip cell culture for dynamic studies of tumor immune surveillance by natural killer cells</article-title>. <source>Lab Chip</source> (<year>2015</year>) <volume>15</volume>:<page-range>3222&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/C5LC00436E</pub-id>
</citation>
</ref>
<ref id="B155">
<label>155</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olofsson</surname> <given-names>K</given-names>
</name>
<name>
<surname>Carannante</surname> <given-names>V</given-names>
</name>
<name>
<surname>Ohlin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Frisk</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kushiro</surname> <given-names>K</given-names>
</name>
<name>
<surname>Takai</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Acoustic formation of multicellular tumor spheroids enabling on-chip functional and structural imaging</article-title>. <source>Lab Chip</source> (<year>2018</year>) <volume>18</volume>:<page-range>2466&#x2013;76</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/c8lc00537k</pub-id>
</citation>
</ref>
<ref id="B156">
<label>156</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandstr&#xf6;m</surname> <given-names>N</given-names>
</name>
<name>
<surname>Carannante</surname> <given-names>V</given-names>
</name>
<name>
<surname>Olofsson</surname> <given-names>K</given-names>
</name>
<name>
<surname>Sandoz</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Moussaud-Lamodi&#xe8;re</surname> <given-names>EL</given-names>
</name>
<name>
<surname>Seashore-Ludlow</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Miniaturized and multiplexed high-content screening of drug and immune sensitivity in a multichambered microwell chip</article-title>. <source>Cell Rep Methods</source> (<year>2022</year>) <volume>2</volume>:<elocation-id>100256</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.crmeth.2022.100256</pub-id>
</citation>
</ref>
<ref id="B157">
<label>157</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiklund</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Acoustofluidics 12: biocompatibility and cell viability in microfluidic acoustic resonators</article-title>. <source>Lab Chip</source> (<year>2012</year>) <volume>12</volume>:<fpage>2018</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/c2lc40201g</pub-id>
</citation>
</ref>
<ref id="B158">
<label>158</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Wiklund</surname> <given-names>M</given-names>
</name>
<name>
<surname>&#xd6;nfelt</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Ultrasonic manipulation of single cells</article-title>. In: <source>Single-Cell Analysis. Methods in Molecular Biology</source> <publisher-name>Humana Press</publisher-name> (<year>2012</year>). <volume>853</volume> p. <page-range>177&#x2013;96</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-1-61779-567-1_14</pub-id>
</citation>
</ref>
<ref id="B159">
<label>159</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiklund</surname> <given-names>M</given-names>
</name>
<name>
<surname>Christakou</surname> <given-names>AE</given-names>
</name>
<name>
<surname>Ohlin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Iranmanesh</surname> <given-names>I</given-names>
</name>
<name>
<surname>Frisk</surname> <given-names>T</given-names>
</name>
<name>
<surname>Vanherberghen</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Ultrasound-induced cell-cell interaction studies in a multi-well microplate</article-title>. <source>Micromachines (Basel)</source> (<year>2014</year>) <volume>5</volume>:<fpage>27</fpage>&#x2013;<lpage>49</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/mi5010027</pub-id>
</citation>
</ref>
<ref id="B160">
<label>160</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanherberghen</surname> <given-names>B</given-names>
</name>
<name>
<surname>Manneberg</surname> <given-names>O</given-names>
</name>
<name>
<surname>Christakou</surname> <given-names>A</given-names>
</name>
<name>
<surname>Frisk</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ohlin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hertz</surname> <given-names>HM</given-names>
</name>
<etal/>
</person-group>. <article-title>Ultrasound-controlled cell aggregation in a multi-well chip</article-title>. <source>Lab Chip</source> (<year>2010</year>) <volume>10</volume>:<page-range>2727&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/c004707d</pub-id>
</citation>
</ref>
<ref id="B161">
<label>161</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christakou</surname> <given-names>AE</given-names>
</name>
<name>
<surname>Ohlin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Vanherberghen</surname> <given-names>B</given-names>
</name>
<name>
<surname>Khorshidi</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Kadri</surname> <given-names>N</given-names>
</name>
<name>
<surname>Frisk</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Live cell imaging in a micro-array of acoustic traps facilitates quantification of natural killer cell heterogeneity</article-title>. <source>Integr Biol (Camb)</source> (<year>2013</year>) <volume>5</volume>:<page-range>712&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/c3ib20253d</pub-id>
</citation>
</ref>
<ref id="B162">
<label>162</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagahashi</surname> <given-names>K</given-names>
</name>
<name>
<surname>Teramura</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Takai</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Stable surface coating of silicone elastomer with phosphorylcholine and organosilane copolymer with cross-linking for repelling proteins</article-title>. <source>Colloids Surf B Biointerfaces</source> (<year>2015</year>) <volume>134</volume>:<page-range>384&#x2013;91</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.colsurfb.2015.07.040</pub-id>
</citation>
</ref>
<ref id="B163">
<label>163</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiessling</surname> <given-names>R</given-names>
</name>
<name>
<surname>Klein</surname> <given-names>E</given-names>
</name>
<name>
<surname>Wigzell</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>"Natural&#x201d; killer cells in the mouse. i. cytotoxic cells with specificity for mouse moloney leukemia cells. specificity and distribution according to genotype</article-title>. <source>Eur J Immunol</source> (<year>1975</year>) <volume>5</volume>:<page-range>112&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.1830050208</pub-id>
</citation>
</ref>
<ref id="B164">
<label>164</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiessling</surname> <given-names>R</given-names>
</name>
<name>
<surname>Klein</surname> <given-names>E</given-names>
</name>
<name>
<surname>Pross</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wigzell</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>"Natural&#x201d; killer cells in the mouse. II. cytotoxic cells with specificity for mouse moloney leukemia cells. characteristics of the killer cell</article-title>. <source>Eur J Immunol</source> (<year>1975</year>) <volume>5</volume>:<page-range>117&#x2013;21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.1830050209</pub-id>
</citation>
</ref>
<ref id="B165">
<label>165</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guldevall</surname> <given-names>K</given-names>
</name>
<name>
<surname>Vanherberghen</surname> <given-names>B</given-names>
</name>
<name>
<surname>Frisk</surname> <given-names>T</given-names>
</name>
<name>
<surname>Hurtig</surname> <given-names>J</given-names>
</name>
<name>
<surname>Christakou</surname> <given-names>AE</given-names>
</name>
</person-group>. <article-title>Imaging immune surveillance of individual natural killer cells confined in microwell arrays</article-title>. <source>PloS One</source> (<year>2010</year>) <volume>5</volume>:<elocation-id>15453</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0015453</pub-id>
</citation>
</ref>
<ref id="B166">
<label>166</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanherberghen</surname> <given-names>B</given-names>
</name>
<name>
<surname>Olofsson</surname> <given-names>PE</given-names>
</name>
<name>
<surname>Forslund</surname> <given-names>E</given-names>
</name>
<name>
<surname>Sternberg-Simon</surname> <given-names>M</given-names>
</name>
<name>
<surname>Khorshidi</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Pacouret</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Classification of human natural killer cells based on migration behavior and cytotoxic response</article-title>. <source>Blood</source> (<year>2013</year>) <volume>121</volume>:<page-range>1326&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2012-06-439851</pub-id>
</citation>
</ref>
<ref id="B167">
<label>167</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guldevall</surname> <given-names>K</given-names>
</name>
<name>
<surname>Brandt</surname> <given-names>L</given-names>
</name>
<name>
<surname>Forslund</surname> <given-names>E</given-names>
</name>
<name>
<surname>Olofsson</surname> <given-names>K</given-names>
</name>
<name>
<surname>Frisk</surname> <given-names>TW</given-names>
</name>
<name>
<surname>Olofsson</surname> <given-names>PE</given-names>
</name>
<etal/>
</person-group>. <article-title>Microchip screening platform for single cell assessment of NK cell cytotoxicity</article-title>. <source>Front Immunol</source> (<year>2016</year>) <volume>7</volume>:<elocation-id>119</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2016.00119</pub-id>
</citation>
</ref>
<ref id="B168">
<label>168</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herberman</surname> <given-names>RB</given-names>
</name>
<name>
<surname>Aoki</surname> <given-names>T</given-names>
</name>
<name>
<surname>Nunn</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lavrin</surname> <given-names>DH</given-names>
</name>
<name>
<surname>Soares</surname> <given-names>N</given-names>
</name>
<name>
<surname>Gazdar</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus</article-title>. <source>J Natl Cancer Inst</source> (<year>1974</year>) <volume>53</volume>:<page-range>1103&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jnci/53.4.1103</pub-id>
</citation>
</ref>
<ref id="B169">
<label>169</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alter</surname> <given-names>G</given-names>
</name>
<name>
<surname>Malenfant</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Altfeld</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>CD107a as a functional marker for the identification of natural killer cell activity</article-title>. <source>J Immunol Methods</source> (<year>2004</year>) <volume>294</volume>:<fpage>15</fpage>&#x2013;<lpage>22</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jim.2004.08.008</pub-id>
</citation>
</ref>
<ref id="B170">
<label>170</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Granger</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Appledorn</surname> <given-names>DM</given-names>
</name>
</person-group>. <article-title>Kinetic measurement of apoptosis and immune cell killing using live-cell imaging and analysis</article-title>. <source>Methods Mol Biol</source> (<year>2021</year>) <volume>2255</volume>:<fpage>197</fpage>&#x2013;<lpage>212</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-1-0716-1162-3_17</pub-id>
</citation>
</ref>
<ref id="B171">
<label>171</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>H&#xf6;ppner</surname> <given-names>M</given-names>
</name>
<name>
<surname>Luhm</surname> <given-names>J</given-names>
</name>
<name>
<surname>Schlenke</surname> <given-names>P</given-names>
</name>
<name>
<surname>Koritke</surname> <given-names>P</given-names>
</name>
<name>
<surname>Frohn</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>A flow-cytometry based cytotoxicity assay using stained effector cells in combination with native target cells</article-title>. <source>J Immunol Methods</source> (<year>2002</year>) <volume>267</volume>:<page-range>157&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0022-1759(02)00167-9</pub-id>
</citation>
</ref>
<ref id="B172">
<label>172</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bryceson</surname> <given-names>YT</given-names>
</name>
<name>
<surname>Fauriat</surname> <given-names>C</given-names>
</name>
<name>
<surname>Nunes</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Wood</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Bj&#xf6;rkstr&#xf6;m</surname> <given-names>NK</given-names>
</name>
<name>
<surname>Long</surname> <given-names>EO</given-names>
</name>
<etal/>
</person-group>. <article-title>Functional analysis of human NK cells by flow cytometry</article-title>. <source>Methods Mol Biol</source> (<year>2010</year>) <volume>612</volume>:<page-range>335&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-1-60761-362-6_23</pub-id>
</citation>
</ref>
<ref id="B173">
<label>173</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Godoy-Ramirez</surname> <given-names>K</given-names>
</name>
<name>
<surname>Franck</surname> <given-names>K</given-names>
</name>
<name>
<surname>Gaines</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>A novel method for the simultaneous assessment of natural killer cell conjugate formation and cytotoxicity at the single-cell level by multi-parameter flow cytometry</article-title>. <source>J Immunol Methods</source> (<year>2000</year>) <volume>239</volume>:<fpage>35</fpage>&#x2013;<lpage>44</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0022-1759(00)00161-7</pub-id>
</citation>
</ref>
<ref id="B174">
<label>174</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Erbe</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Gallenberger</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hank</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Sondel</surname> <given-names>PM</given-names>
</name>
</person-group>. <source>Natural killer cells</source>. <person-group person-group-type="editor">
<name>
<surname>Somanchi</surname> <given-names>SS</given-names>
</name>
</person-group>, editor. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer New York</publisher-name> (<year>2016</year>) p. <page-range>4370&#x2013;1</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-1-4939-3684-7</pub-id>
</citation>
</ref>
<ref id="B175">
<label>175</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brunner</surname> <given-names>KT</given-names>
</name>
<name>
<surname>Mauel</surname> <given-names>J</given-names>
</name>
<name>
<surname>Cerottini</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Chapuis</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Quantitative assay of the lytic action of immune lymphoid cells on 51-cr-labelled allogeneic target cells <italic>in vitro</italic>; inhibition by isoantibody and by drugs</article-title>. <source>Immunology</source> (<year>1968</year>) <volume>14</volume>:<page-range>181&#x2013;96</page-range>.</citation>
</ref>
<ref id="B176">
<label>176</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirte</surname> <given-names>HW</given-names>
</name>
<name>
<surname>Clark</surname> <given-names>DA</given-names>
</name>
</person-group>. <article-title>Factors determining the ability of cytokine-activated killer cells to lyse human ovarian carcinoma targets</article-title>. <source>Cell Immunol</source> (<year>1991</year>) <volume>136</volume>:<page-range>122&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0008-8749(91)90387-Q</pub-id>
</citation>
</ref>
<ref id="B177">
<label>177</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmit</surname> <given-names>T</given-names>
</name>
<name>
<surname>Klomp</surname> <given-names>M</given-names>
</name>
<name>
<surname>Khan</surname> <given-names>MN</given-names>
</name>
</person-group>. <article-title>An overview of flow cytometry: its principles and applications in allergic disease research</article-title>. <source>Methods Mol Biol</source> (<year>2021</year>) <volume>2223</volume>:<page-range>169&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-1-0716-1001-5_13</pub-id>
</citation>
</ref>
<ref id="B178">
<label>178</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Velden</surname> <given-names>VHJ</given-names>
</name>
<name>
<surname>Scid</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Modern flow cytometry</article-title>. <source>Erasmus</source> (<year>2015</year>) <volume>83</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>6</lpage>.</citation>
</ref>
<ref id="B179">
<label>179</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shapiro</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Telford</surname> <given-names>WG</given-names>
</name>
</person-group>. <article-title>Lasers for flow cytometry: current and future trends</article-title>. <source>Curr Protoc Cytom</source> (<year>2018</year>) <volume>83</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/cpcy.30</pub-id>
</citation>
</ref>
<ref id="B180">
<label>180</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Meer</surname> <given-names>JMR</given-names>
</name>
<name>
<surname>Maas</surname> <given-names>RJA</given-names>
</name>
<name>
<surname>Guldevall</surname> <given-names>K</given-names>
</name>
<name>
<surname>Klarenaar</surname> <given-names>K</given-names>
</name>
<name>
<surname>de Jonge</surname> <given-names>PKJD</given-names>
</name>
<name>
<surname>Evert</surname> <given-names>JSHH</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-15 superagonist n-803 improves IFN&#x3b3; production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells</article-title>. <source>Cancer Immunology Immunotherapy</source> (<year>2021</year>) <volume>70</volume>:<page-range>1305&#x2013;21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00262-020-02749-8</pub-id>
</citation>
</ref>
<ref id="B181">
<label>181</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holmes</surname> <given-names>TD</given-names>
</name>
<name>
<surname>El-Sherbiny</surname> <given-names>YM</given-names>
</name>
<name>
<surname>Davison</surname> <given-names>A</given-names>
</name>
<name>
<surname>Clough</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Blair</surname> <given-names>GE</given-names>
</name>
<name>
<surname>Cook</surname> <given-names>GP</given-names>
</name>
</person-group>. <article-title>A human NK cell Activation/Inhibition threshold allows small changes in the target cell surface phenotype to dramatically alter susceptibility to NK cells</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>186</volume>:<page-range>1538&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1000951</pub-id>
</citation>
</ref>
<ref id="B182">
<label>182</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morimoto</surname> <given-names>T</given-names>
</name>
<name>
<surname>Nakazawa</surname> <given-names>T</given-names>
</name>
<name>
<surname>Matsuda</surname> <given-names>R</given-names>
</name>
<name>
<surname>Nishimura</surname> <given-names>F</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yamada</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Evaluation of comprehensive gene expression and NK cell-mediated killing in glioblastoma cell line-derived spheroids</article-title>. <source>Cancers (Basel)</source> (<year>2021</year>) <volume>13</volume>:<elocation-id>4896</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cancers13194896</pub-id>
</citation>
</ref>
<ref id="B183">
<label>183</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veneziani</surname> <given-names>I</given-names>
</name>
<name>
<surname>Infante</surname> <given-names>P</given-names>
</name>
<name>
<surname>Ferretti</surname> <given-names>E</given-names>
</name>
<name>
<surname>Melaiu</surname> <given-names>O</given-names>
</name>
<name>
<surname>Battistelli</surname> <given-names>C</given-names>
</name>
<name>
<surname>Lucarini</surname> <given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Nutlin-3a enhances natural killer cell&#x2013;mediated killing of neuroblastoma by restoring p53-dependent expression of ligands for NKG2D and DNAM-1 receptors</article-title>. <source>Cancer Immunol Res</source> (<year>2021</year>) <volume>9</volume>:<page-range>170&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/2326-6066.CIR-20-0313</pub-id>
</citation>
</ref>
<ref id="B184">
<label>184</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cristaldi</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Sargenti</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bonetti</surname> <given-names>S</given-names>
</name>
<name>
<surname>Musmeci</surname> <given-names>F</given-names>
</name>
<name>
<surname>Delprete</surname> <given-names>C</given-names>
</name>
<name>
<surname>Bacchi</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>A reliable flow-based method for the accurate measure of mass density, size and weight of live 3D tumor spheroids</article-title>. <source>Micromachines (Basel)</source> (<year>2020</year>) <volume>11</volume>:<fpage>1</fpage>&#x2013;<lpage>13</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/mi11050465</pub-id>
</citation>
</ref>
<ref id="B185">
<label>185</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kl&#xf6;ss</surname> <given-names>S</given-names>
</name>
<name>
<surname>Chambron</surname> <given-names>N</given-names>
</name>
<name>
<surname>Gardlowski</surname> <given-names>T</given-names>
</name>
<name>
<surname>Weil</surname> <given-names>S</given-names>
</name>
<name>
<surname>Koch</surname> <given-names>J</given-names>
</name>
<name>
<surname>Esser</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Cetuximab reconstitutes pro-inflammatory cytokine secretions and tumor-infiltrating capabilities of sMICA-inhibited NK cells in HNSCC tumor spheroids</article-title>. <source>Front Immunol</source> (<year>2015</year>) <volume>6</volume>:<elocation-id>543</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2015.00543</pub-id>
</citation>
</ref>
<ref id="B186">
<label>186</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carannante</surname> <given-names>V</given-names>
</name>
<name>
<surname>Sandstr&#xf6;m</surname> <given-names>N</given-names>
</name>
<name>
<surname>Olofsson</surname> <given-names>K</given-names>
</name>
<name>
<surname>Van Ooijen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Hell</surname> <given-names>B</given-names>
</name>
<name>
<surname>Wiklund</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>&#x201c;Generation of tumor spheroids in microwells to study NK cell cytotoxicity, infiltration and phenotype.,&#x201d;</article-title>. <source>Methods Cell Biol Acad Press</source> (<year>2023</year>). doi:&#xa0;<pub-id pub-id-type="doi">10.1016/bs.mcb.2023.01.001</pub-id>
</citation>
</ref>
<ref id="B187">
<label>187</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>S&#xe4;rchen</surname> <given-names>V</given-names>
</name>
<name>
<surname>Shanmugalingam</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kehr</surname> <given-names>S</given-names>
</name>
<name>
<surname>Reindl</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Greze</surname> <given-names>V</given-names>
</name>
<name>
<surname>Wiedemann</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Pediatric multicellular tumor spheroid models illustrate a therapeutic potential by combining BH3 mimetics with natural killer (NK) cell-based immunotherapy</article-title>. <source>Cell Death Discovery</source> (<year>2022</year>) <volume>8</volume>:<fpage>11</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41420-021-00812-6</pub-id>
</citation>
</ref>
<ref id="B188">
<label>188</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edwards</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Carannante</surname> <given-names>V</given-names>
</name>
<name>
<surname>Kuhnigk</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ring</surname> <given-names>H</given-names>
</name>
<name>
<surname>Tararuk</surname> <given-names>T</given-names>
</name>
<name>
<surname>Hallb&#xf6;&#xf6;k</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>High-resolution imaging of tumor spheroids and organoids enabled by expansion microscopy</article-title>. <source>Front Mol Biosci</source> (<year>2020</year>) <volume>7</volume>:<elocation-id>208</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmolb.2020.00208</pub-id>
</citation>
</ref>
<ref id="B189">
<label>189</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huisken</surname> <given-names>J</given-names>
</name>
<name>
<surname>Swoger</surname> <given-names>J</given-names>
</name>
<name>
<surname>del Bene</surname> <given-names>F</given-names>
</name>
<name>
<surname>Wittbrodt</surname> <given-names>J</given-names>
</name>
<name>
<surname>Stelzer</surname> <given-names>EHK</given-names>
</name>
</person-group>. <article-title>Optical sectioning deep inside live embryos by selective plane illumination microscopy</article-title>. <source>Science</source> (<year>2004</year>) <volume>305</volume>:<page-range>1007&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1100035</pub-id>
</citation>
</ref>
<ref id="B190">
<label>190</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Weber</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mickoleit</surname> <given-names>M</given-names>
</name>
<name>
<surname>Huisken</surname> <given-names>J</given-names>
</name>
</person-group>. <source>Light sheet microscopy</source>. <edition>1st ed</edition>. <publisher-name>Elsevier Inc</publisher-name> (<year>2014</year>) p. <fpage>193</fpage>&#x2013;<lpage>215</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/B978-0-12-420138-5.00011-2</pub-id>
</citation>
</ref>
<ref id="B191">
<label>191</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reynaud</surname> <given-names>EG</given-names>
</name>
<name>
<surname>Kr&#x17e;i&#x10d;</surname> <given-names>U</given-names>
</name>
<name>
<surname>Greger</surname> <given-names>K</given-names>
</name>
<name>
<surname>Stelzer</surname> <given-names>EHK</given-names>
</name>
</person-group>. <article-title>Light sheet-based fluorescence microscopy: more dimensions, more photons, and less photodamage</article-title>. <source>HFSP J</source> (<year>2008</year>) <volume>2</volume>:<page-range>266&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2976/1.2974980</pub-id>
</citation>
</ref>
<ref id="B192">
<label>192</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lorenzo</surname> <given-names>C</given-names>
</name>
<name>
<surname>Frongia</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jorand</surname> <given-names>R</given-names>
</name>
<name>
<surname>Fehrenbach</surname> <given-names>J</given-names>
</name>
<name>
<surname>Weiss</surname> <given-names>P</given-names>
</name>
<name>
<surname>Maandhui</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Live cell division dynamics monitoring in 3D large spheroid tumor models using light sheet microscopy</article-title>. <source>Cell Div</source> (<year>2011</year>) <volume>6</volume>:<elocation-id>22</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1747-1028-6-22</pub-id>
</citation>
</ref>
<ref id="B193">
<label>193</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krneta</surname> <given-names>T</given-names>
</name>
<name>
<surname>Gillgrass</surname> <given-names>A</given-names>
</name>
<name>
<surname>Chew</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ashkar</surname> <given-names>AA</given-names>
</name>
</person-group>. <article-title>The breast tumor microenvironment alters the phenotype and function of natural killer cells</article-title>. <source>Cell Mol Immunol</source> (<year>2016</year>) <volume>13</volume>:<page-range>628&#x2013;39</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/cmi.2015.42</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>